Scolaris Content Display Scolaris Content Display

Humidificación del aire en interiores para prevenir o reducir los síntomas de sequedad o las infecciones de las vías respiratorias altas en entornos educativos y en el lugar de trabajo

Contraer todo Desplegar todo

Antecedentes

La exposición al aire seco en interiores durante los periodos de calefacción se ha asociado con síntomas de sequedad e irritación de las vías respiratorias altas y de la piel. La membrana mucosa irritada o dañada constituye un importante puerto de entrada para los agentes patógenos que causan las infecciones respiratorias.

Objetivos

Determinar la efectividad de las intervenciones que aumentan la humedad del aire en interiores para reducir o prevenir los síntomas de sequedad ocular, cutánea y de las vías respiratorias altas (VRA) o las infecciones de las VRA, en el trabajo y en entornos educativos.

Métodos de búsqueda

La última búsqueda en todas las bases de datos se realizó en diciembre de 2020. Se hicieron búsquedas en Ovid MEDLINE, Embase, CENTRAL (Biblioteca Cochrane), PsycINFO, Web of Science, Scopus y en el ámbito de seguridad y salud laboral: NIOSHTIC‐2, HSELINE, CISDOC y la base de datos interna de la División de medicina laboral y ambiental de la Universidad de Zúrich. También se estableció contacto con expertos, se comprobaron las listas de referencias de ensayos incluidos, las revisiones relevantes y se consultó la Plataforma de registros internacionales de ensayos clínicos (ICTRP) de la OMS.

Criterios de selección

Se incluyeron estudios controlados con un diseño de grupos paralelos o cruzados (cross‐over), estudios cuasialeatorizados, estudios controlados tipo antes y después y estudios de series de tiempo interrumpido sobre los efectos de la humidificación del aire en interiores para reducir o prevenir los síntomas de sequedad y las infecciones de las vías respiratorias altas como desenlaces principales en el lugar de trabajo y en el entorno educativo. Como desenlaces secundarios se consideraron la calidad del aire percibida, otros eventos adversos, las bajas por enfermedad, la realización de las tareas, la productividad y la asistencia, así como los costes de la intervención.

Obtención y análisis de los datos

Dos autores de la revisión de forma independiente comprobaron la elegibilidad de los títulos, los resúmenes y los textos completos, extrajeron los datos, y evaluaron los riesgos de sesgo de los estudios incluidos. Se resumió la evidencia para los desenlaces principales "ojo seco", "nariz seca", "piel seca", para el desenlace secundario "absentismo", así como para la "percepción de aire cargado" como medida relacionada con el efecto perjudicial. La certeza de la evidencia se evaluó con el método GRADE.

Resultados principales

Se incluyeron 13 estudios con al menos 4551 participantes, y se extrajeron los datos de 12 estudios con al menos 4447 participantes. Siete estudios se centraron en el ámbito laboral, tres de ellos con trabajadores de oficina y cuatro con personal hospitalario. Tres de estos fueron estudios cruzados por conglomerados con 846 participantes (un ensayo cuasialeatorizado), uno fue un ensayo controlado de grupos paralelos (2395 participantes) y tres fueron estudios controlados tipo antes y después con 181 participantes. Entre 1963 y 1975 y en 2018 se notificaron cinco estudios, todos ensayos controlados, con al menos 1025 participantes, que se centraron en el entorno educativo. En total se incluyeron al menos 3933 (88%) participantes en los análisis de datos.

Debido a la falta de información, los resultados de la evaluación del riesgo de sesgo siguieron siendo principalmente inciertos y los riesgos de sesgo evaluables de los estudios incluidos se consideraron predominantemente altos.

Desenlaces principales en el ámbito laboral:

Se ha observado que la humidificación del aire en interiores en el lugar de trabajo podría tener un efecto escaso o nulo sobre los síntomas de sequedad ocular y nasal (VRA). El único ensayo cuasialeatorizado mostró una reducción significativa de los síntomas de sequedad ocular en trabajadores adultos (odds ratio [OR] 0,54; intervalo de confianza [IC] del 95%: 0,37 a 0,79) con una evidencia de certeza baja. El único estudio cruzado no aleatorizado por conglomerados mostró un efecto positivo no significativo de la humidificación sobre los síntomas de sequedad nasal (OR 0,87; IC del 95%: 0,53 a 1,42) con una evidencia de certeza baja.

Se observó que la humidificación del aire en interiores en el lugar de trabajo podría tener un efecto escaso y no significativo sobre los síntomas de sequedad cutánea. Los resultados agrupados de dos ensayos no aleatorizados por conglomerados mostraron un alivio no significativo de la sequedad cutánea tras la humidificación del aire en interiores (OR 0,66; IC del 95%: 0,33 a 1,32) con una evidencia de certeza baja. Del mismo modo, los resultados agrupados de dos estudios tipo antes y después no arrojaron ningún resultado estadísticamente significativo (OR 0,69; IC del 95%: 0,33 a 1,47) con una evidencia de certeza muy baja.

Ningún estudio informó sobre el desenlace de infecciones de las vías respiratorias altas.

Ningún estudio realizado en entornos educativos investigó los desenlaces principales de esta revisión.

Desenlaces secundarios en el ámbito laboral:

La percepción de aire cargado aumentó durante la humidificación en los dos estudios cruzados (OR 2,18; IC del 95%: 1,47 a 3,23); (OR 1,70; IC del 95%: 1,10 a 2,61) con una evidencia de certeza baja.

Desenlaces secundarios en el entorno educativo:

Según diferentes medidas y contextos de absentismo, cuatro de los seis estudios controlados encontraron una reducción del absentismo tras la humidificación del aire en interiores (OR 0,54; IC del 95%: 0,45 a 0,65; OR 0,38; IC del 95%: 0,15 a 0,96; proporción 4,63% versus 5,08%).

Conclusiones de los autores

La humidificación del aire en interiores en el lugar de trabajo podría tener un efecto escaso o nulo sobre los síntomas de sequedad ocular, cutánea y de las VRA. Los estudios que investigaron el absentismo laboral o escolar por enfermedad solo pudieron resumirse narrativamente, debido a las diferentes medidas de desenlace evaluadas. La evidencia indica que aumentar la humidificación podría reducir el absentismo, pero es muy incierta. Por lo tanto, se necesitan futuros ECA que incluyan tamaños muestrales más grandes, que evalúen los síntomas de sequedad de forma más técnica o que definan rigurosamente el absentismo y controlen los posibles factores de confusión para determinar si el aumento de la humedad del aire en interiores puede reducir o prevenir los síntomas de sequedad ocular, cutánea o de las VRA o las infecciones de las VRA en el lugar de trabajo y en entornos educativos a lo largo del tiempo.

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.

Intervenciones para prevenir o reducir los síntomas de sequedad o las infecciones de las vías respiratorias altas en entornos educativos y en el lugar de trabajo

El objetivo fue averiguar si la humidificación del aire en interiores puede prevenir o reducir los síntomas de sequedad o las infecciones de las vías respiratorias altas en entornos educativos y en el lugar de trabajo.

Durante el periodo de calefacción, la humedad del aire interior es baja, lo que puede provocar molestias como sequedad de ojos, nariz, garganta y piel. Además, la sequedad e irritación de la mucosa puede provocar, a su vez, susceptibilidad a las infecciones de las vías respiratorias superiores. Estas afecciones también podrían estar asociadas con no asistir al trabajo y al colegio. Aumentar la humedad del aire en interiores mediante humidificadores podría prevenir o reducir los síntomas de sequedad o las infecciones de las vías respiratorias altas.

Estudios encontrados:

Se incluyeron 13 estudios con 4551 participantes. Siete estudios se llevaron a cabo en el lugar de trabajo (en hospitales y en oficinas) y cinco estudios se realizaron en entornos educativos (escuelas de educación infantil y primaria). No fue posible analizar los datos de un estudio para el propósito de esta revisión.

Humidificación del aire en interiores comparada con no humidificar

Los estudios incluidos mostraron que el aumento de la humedad del aire en interiores mediante la instalación de humidificadores en los lugares de trabajo no tuvo ningún efecto, y otros estudios mostraron una reducción de los síntomas de sequedad de los ojos, la piel y las vías respiratorias altas. Sin embargo, la calidad de la evidencia fue baja a muy baja.

En cuanto al absentismo, los resultados de los estudios (la mayoría de ellos realizados en el entorno educativo) tampoco son consistentes. La certeza de la evidencia fue muy baja.

Calidad de la evidencia

Se consideró que la certeza de la evidencia era de baja a muy baja por limitaciones en los estudios. Esto significa que no es posible confiar en los hallazgos globales.

¿Qué es lo que todavía se debe averiguar?

Se necesitan estudios de mayor certeza, con definiciones y mediciones precisas de los síntomas.

Authors' conclusions

Implications for practice

The question of whether humidification of indoor air prevents or alleviates dryness symptoms of the skin and mucosal membranes and reduces upper respiratory tract infections in workplaces and in kindergarten or at schools is important from a public health and occupational health perspective. The prevention of symptoms and upper airway infections has a positive impact on well‐being, performance and health. It therefore contributes, together with the reduction in absenteeism, to a positive socio‐economic impact.

During the heating period, humidification is commonly used in current practice in some countries in many buildings. Various studies have shown that low humidity at different levels causes dryness symptoms of the eye, upper respiratory system and skin in the form of itching or burning, and humidification may alleviate these complaints. According to the results from the included studies in our review, it was not possible to define a comfort zone for the humidity level in indoor spaces in wintertime. Hence, we could not assess whether the current praxis for optimal humidity level is justified. The number of available studies was too small, and they were too heterogeneous. The investigated populations were exposed to different ranges of RH in the control and intervention groups.

It should be borne in mind that active humidification can lead to adverse events, as exemplified in many studies.

Implications for research

We found inconsistent and low to very low‐certainty evidence that indoor air humidification in the workplace decreased dryness symptoms of the eye, upper respiratory tract and the skin. Studies investigating illness‐related absenteeism from work or school could only be summarised narratively, due to different assessments of the outcomes. They were of very low‐certainty evidence. However, they might be indicative of an intervention effect. Future studies involving larger sample sizes (according to the power calculations), assessing dryness symptoms more technically or rigorously defining absenteeism and controlling for potential confounders are therefore needed to determine whether increasing indoor air humidity can reduce or prevent dryness symptoms of the eyes, the skin, the upper respiratory tract (URT) or URT infections at work and in educational settings over time.

Outcomes should be better defined (according to medical definitions) and consistent definitions should be used in future studies. Using validated questionnaires for symptom assessment will contribute to better measurement accuracy, reliability and sensitivity. Researchers should conduct objective measurements of physiological changes in the upper respiratory airways, skin and eyes due to humidification, alongside subjective outcome assessments. This will enable better comparability of the studies and improve their informative value.

Summary of findings

Open in table viewer
Summary of findings 1. Summary of findings table 'dryness symptoms'

Indoor air humidification compared with no indoor air humidification for prevention or reducing dryness symptoms of the eyes, skin and nose (URT)

Population: Adults
Setting: Occupational
Intervention: Indoor air humidification
Comparison: No indoor air humidification

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of participants
(studies)#

Quality of the evidence
(GRADE)

Comments

Risk with no humidification

Risk with humidification

Dry eye

Cross‐over study (cluster‐RCT) after 6 weeks

Study population

OR 0.54
(0.37 to 0.79)

211
(1 cross‐over cluster‐RCT)

⊕⊕⊝⊝
LOWa

The cluster‐randomised cross‐over study reported a significant reduction in eye dryness following indoor air humidification over a study period of 6 weeks

359 per 1000

232 per 1000
(172 to 307)

Dry eye

Cross‐over studies (cluster non‐RCT) after 6 – 12 weeks

Study population

OR 0.58
(0.27 to 1.25)

407
(2 cross‐over cluster non‐RCTs)

⊕⊕⊝⊝
LOW

2 cluster non‐randomised cross‐over studies reported non‐significant positive effects on eye dryness following indoor air humidification over a study period of 1 ‐ 3 months

359 per 1000

245 per 1000
(131 to 412)

Dry eye

Before‐and‐after studies after 6 weeks ‐ 4 months

Study population

OR 0.57
(0.23 to 1.41)

102
(2 before‐and‐after studies)

⊕⊝⊝⊝
VERY LOWb, c

2 before‐and‐after studies showed non‐significant positive effect of indoor air humidification on dry eye symptoms over a study period of 6 weeks to 4 months

359 per 1000

242 per 1000
(114 to 441)

 

Dry skin

Cross‐over studies (cluster non‐RCT) after 6 ‐ 12 weeks

Study population

OR 0.66
(0.33 to 1.32)

407
(2 non‐RCT)

⊕⊕⊝⊝
LOW

Both cluster non‐randomised cross‐over studies showed an alleviation of skin dryness following indoor air humidification over a study period of 1 ‐ 3 months

380 per 1'000

288 per 1000
(168 to 447)

Dry skin

Before‐and‐after Studies after 12 weeks to 4 months

Study population

OR 0.69
(0.33 to 1.47)

121
(2 before‐and‐after studies)

⊕⊝⊝⊝
VERY LOWd

1 before‐and‐after study yielded a positive effect of indoor air humidification on skin dryness over a study period of 12 weeks.

1 before‐and‐after study showed no effect following indoor air humidification over a study period of 4 months

380 per 1000

297 per 1000
(168 to 474)

 

Dry nose (dry upper respiratory tract)

Cross‐over study (cluster non‐RCT) after 6 weeks

Study population

OR 0.87
(0.53 to 1.42)

368

(1 non‐RCT)

⊕⊕⊝⊝
LOW

The cluster non‐randomised cross‐over study reported an alleviation of nose dryness following indoor air humidification over a study period of 6 weeks. Hence, the result was not statistically significant

246 per 1000

221 per 1000
(147 to 317)

Dry nose (dry upper respiratory tract)

Cross‐over study (cluster‐RCT) after 6 weeks

Study population

OR 1.08
(0.73 to 1.60)

211
(1 RCT)

⊕⊕⊝⊝
LOWd

The cluster‐randomised cross‐over study revealed no effect of indoor air humidification on nose dryness over a study period of 6 weeks

246 per 1000

259 per 1000
(194 to 337)

 

No studies were identified for URT (Upper respiratory infections)

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
#Number of participants included in the analysis were reported, See Characteristics of included studies for number of recruited and included participants.
CI: Confidence interval; OR: Odds ratio; RCT: randomised controlled trial

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

aDowngraded twice due to high risk of bias: there were missing outcome data (the reason was not stated); the items: randomisation, allocation concealment, blinding unclear, selective outcome reporting were unclear.
bDowngraded twice due to high risk of bias: in one study the percentage of withdrawals and dropouts exceeds 20% for short‐term follow‐up and the results are presented for a dynamic population.
cDowngraded once due to imprecision: small sample sizes.
dDowngraded once due to high risk of bias: lack of control for confounding and other source of bias (dynamic population).

We did not upgrade any of the individual studies.

Open in table viewer
Summary of findings 2. Summary of findings table 'adverse effects' 

Humidification compared to no humidification for preventing or reducing of perception of stuffiness

Population: Adults
Setting: Occupational
Intervention: Indoor air humidification
Comparison: No indoor air humidification

Outcomes

Anticipated absolute effects* (95% CI)

Relative effect
(95% CI)

№ of participants
(studies)#

Certainty of the evidence
(GRADE)

Comments

Risk with no humidification

Risk with humidification

Perception of stuffiness: Cross‐over study (cluster‐RCT) after 6 weeks

246 per 1000

416 per 1000
(324 to 513)

OR 2.18
(1.47 to 3.23)

211
(1 cross‐over cluster‐RCT)

⊕⊕⊝⊝
LOWa

The clustered randomised cross‐over study reported more frequent perception of stuffiness over a study period of 6 weeks

Perception of stuffiness: Cross‐over study (cluster non‐RCT) after 6 weeks

246 per 1000

357 per 1000
(264 to 460)

OR 1.70
(1.10 to 2.61)

368

(1 non‐RCT)

⊕⊕⊝⊝
LOW

The cluster‐non‐randomised cross‐over study reported more frequent perception of stuffiness over a study period of 6 weeks

Perception of stuffiness: 2 Before‐and‐after studies after 1‐4 months

246 per 1000

148 per 1000

(‐74 to 192)

St. Mean Diff.

0.24
(−0.30 to 0.78)

102
(2 before‐and‐after studies)

⊕⊝⊝⊝
VERY LOWb, c

2 before‐and‐after studies showed a non‐significant positive effect of indoor air humidification for the perception of stuffy air over a study period of 6 weeks to 4 months

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
# Number of participants included in the analysis were reported, See Characteristics of included studies for number of recruited and included participants.
CI: Confidence interval; OR: Odds ratio; RCT: randomised controlled trial

GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

aDowngraded twice due to high risk of bias: there were missing outcome data (the reason was not stated); the items: randomisation, allocation concealment, blinding unclear, selective outcome reporting were unclear.
bDowngraded twice due to high risk of bias: in one study the percentage of withdrawals and dropouts exceeds 20% for short‐term follow‐up and the results are presented for a dynamic population.
cDowngraded once due to imprecision: small sample sizes.

Open in table viewer
Summary of findings 3. Summary of findings 'absenteeism'

Indoor air humidification compared with no indoor air humidification for prevention or reducing absenteeism

Patient or population: Children

Settings: Educational

Intervention: Indoor air humidification

Comparison: No indoor air humidification

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of Participants
(studies)#

Quality of the evidence
(GRADE)

Assumed risk

Corresponding risk

No indoor air humidification

Indoor air humidification

In total 6 non‐randomised, parallel‐group controlled studies were included, 5 in educational and one in an occupational setting. Different outcomes were assessed.

Absenteeism due to cold symptoms

1 study showed a statistically significant reduction in absenteeism due to cold symptoms following indoor air humidification

OR 0.54 (0.45 to 0.65)

232

1 study

⊕⊝⊝⊝
VERY LOWa

Average days of absence per child

No reduction in respiratory illness could be demonstrated following indoor air humidification in 1 study.

 

162

1 study

⊕⊝⊝⊝
VERY LOWa, b

Average weekly absence

1 study revealed a statistically significant decrease in average weekly absence following indoor air humidification.

OR 0.38 (0.15 to 0.96)

263

1 study

⊕⊝⊝⊝
VERY LOWa, c

Average total absenteeism

10‐year‐average of total absenteeism: under humidified condition 4.63% and under non‐humidified condition 5.08%, statistical significance at 95% CI level reported, data not shown

 

N unknown

(12 schools, grades 1 ‐ 8)

⊕⊝⊝⊝
VERY LOWa

Absenteeism due to sickness

In the humidified group the absenteeism due to sickness was the same as in the control group.

 

116

1 study

⊕⊝⊝⊝
VERY LOWa

Absenteeism due to influenza‐like illness

The percentage of students with influenza‐like illness absences was lower under the humidified vs. the non‐humidified condition

 

116

1 study

⊕⊝⊝⊝
VERY LOWa

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).

#Number of participants included in the analysis were reported, See Characteristics of included studies for number of recruited and included participants.
CI: Confidence interval; OR: Odds Ratio

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

aDowngraded once due to high risk of bias: lack of control for confounding.
bDowngraded once due to high risk of bias: Lack of blinding.
cDowngraded once due to high risk of bias: Other source of bias.

Background

Following the progress of industrialisation, workplaces have increasingly moved from outdoor to indoor locations. This shift has changed the spectrum of conditions to which workers are exposed. This fact is not only relevant to the adult working population, but also to children and young adults, as they stay indoors for a significant part of the day throughout their education (Angelon‐Gaetz 2014; Jaakkola 1991; Seppanen 2002). At most workplaces, indoor air is a predefined condition. Its components vary considerably among different occupational and educational settings. Emissions from indoor sources like building materials, furnishings, office equipment and human activities result in the release of dust as well as chemical and biological compounds. Following natural ventilation, outdoor factors, such as pollen and particulate matters, may also contribute to indoor air quality (Alsmo 2014). Indoor air climate results from a combination of four physical parameters: temperature, radiation temperature, air velocity, and humidity. Humidity is defined as absolute humidity (water vapour content of the air) whilst relative humidity (RH) is the ratio of vapour pressure and saturation vapour pressure. RH, expressed as a percentage, increases relative to a decrease in temperature. A humidity level of 100% means that the air is completely saturated with water vapour. The influence of different humidity levels on pathogens, allergens and chemical factors is presented in Figure 1 (Alsmo 2014).


Association of indoor relative humidity and exposure factors related to adverse health effects (Alsmo 2014)

Association of indoor relative humidity and exposure factors related to adverse health effects (Alsmo 2014)

Description of the condition

The context of indoor air humidity and health is not a new issue, with the concept of dry air being associated with poor air quality since the early 20th century (Watt 1910). Currently, there is no universal definition of dry air. It is in fact difficult to ascertain how and to what extent human beings perceive air humidity (Von Hahn 2007), as we do not have any specific receptors to trace it directly. As the perception of dry air is strongly affected by climatic parameters (particularly temperature) and environmental factors (e.g. dust), even RH levels of 50% can be experienced as dry air under certain conditions (Von Hahn 2007). Nevertheless, many recommend avoiding conditions below a lower limit of RH of 30% to 40%, as such conditions would commonly be perceived as uncomfortable (Von Hahn 2007).

Naturally‐ventilated places have substantially lower levels of RH in winter than in summer. The colder it is outside and the better a building is naturally ventilated, the drier the indoor air becomes.

In cold seasons, building occupants increasingly complain about dryness of the eyes, throat and skin in close temporal relation to exposure to dry air at the workplace (Von Hahn 2007). These symptoms lack specificity and it is therefore difficult to attribute them to clearly‐defined triggers. Furthermore, they can emerge through various pathways and, for instance, it may remain difficult to distinguish between symptoms due to immunological and inflammatory mechanisms. Some of these complaints are assumed to be directly associated with low levels of RH. However, most of them seem to be multifactorial in origin. In addition, they could also be the result of an indirect influence of RH due to interactions, for example with chronic illness. Individuals with certain pre‐existing medical conditions and predisposed individuals appear to be more affected.

Ocular symptoms such as burning, itching, and sensations of dryness and stinging are summarised as eye irritation (Wolkoff 2008). These complaints occur commonly at the workplace, especially in women (Wolkoff 2010). The prevalence of discomfort varies considerably and ranges from 5.5% to 33.7% across studies, depending on the investigated population and the diagnostic criteria (Lin 2003). Overall, office workers suffer more frequently from eye irritation than the general population (Wolkoff 2008). A low humidity level (5% to 30%) is an environmental risk factor that contributes to an increased prevalence of dry eyes in office environments (Wolkoff 2008). However, there is a wide range of individual and external risk factors associated with eye irritation in the office environment (Wolkoff 2008). Age, medication and hormonal changes represent personal risk factors for developing ocular symptoms (Wolkoff 2010). Exposure to ambient irritants such as formaldehyde and ozone can cause sensory irritation in the eyes by trigeminal stimulation (Wolkoff 2010). The impact of concomitant exposure to sensory irritants (e.g. volatile organic compounds (VOCs) and ozone) and dry air on the eye has been shown to be greater at a relative humidity level of 20% compared to 50% (Wolkoff 2005). Furthermore, irritated eye symptoms resulting from exposure to low humidity levels might be exacerbated by computer screen work (Wolkoff 2007).

The mucous membrane of the airways poses a natural barrier protecting against irritants, microbes and unfavourable climatic conditions. The interaction of ciliary activity and viscosity of mucosal fluid is crucial for its self‐cleaning properties (Guggenbichler 2007). This mechanism is called mucociliary clearance, and can be assessed using different methods. In the airways, the air is conditioned to 37 °C and 100% relative humidity, regardless of the ambient conditions (Pfluger 2013). However, despite this compensatory mechanism, exposure to dry air seems to induce dryness and irritation symptoms, as has been shown in several epidemiological studies (Ghaved 2005Reinikainen 1991; Reinikainen 1992). Alongside age, air humidity and hydration status, there are many other internal and external risk factors affecting mucous membrane function.

Among occupants of buildings, the baseline prevalence of nasal symptoms is often 20% (Bascom 1991). Building occupants exposed to chemical and microbiological VOCs can develop symptoms of mucosal irritation in the eyes and upper airways by trigeminal stimulation, even at levels below threshold values (Wolkoff 2013). Concomitant exposure to low humidity may lead to instability of the mucous membrane and consequently to lowering the threshold of sensory irritation (Wolkoff 2013).

Occupants permanently exposed to low humidity commonly complain of dry, brittle and cracked skin (Pfluger 2013). Rycroft 1980 describes two outbreaks of dermatosis (pruritus, urticaria, erythema, oedema and scaling of the skin) relating to working environments with low RH (35%). Exposure to allergens and irritants at the workplace or at home may also lead to dryness or irritation symptoms of the skin and the development of dermatitis.

Several, mostly older, epidemiological studies have evaluated the effect of humidity on the incidence of respiratory infections (Arundel 1986). Most found a lower rate of respiratory infections in rooms with higher humidity compared to those with lower humidity. Most of these studies were conducted among preschool or school children, with only two studies conducted in adult workers. These latter two studies (Gubéran 1978Serati 1969) found non‐significant differences in absenteeism due to respiratory tract infections between humidified and non‐humidified offices.

Experimental studies have shown that low humidity and low temperature promote the spread of the influenza virus. The winter time in temperate countries associated with exposure to cold air outdoors and its relationship with dry air indoors may therefore explain the seasonality of influenza (Lowen 2014). Humidification of a building is often coupled with airflow and ventilation, which have also been found to influence the rate of transmission of respiratory tract viruses (Pica 2012).

Dryness of the eye, skin and URT, as well as fatigue and headache, are used to describe the term 'sick building syndrome' (SBS) (Joshi 2008Norbäck 2009). These complaints seem to be directly linked to the time spent in a particular building. According to Burge 2004, air‐conditioned buildings generally have a higher prevalence of symptomatic workers than those which are naturally ventilated. Although affected individuals perceive the sensation of dryness in enclosed spaces, it has been shown that they are not exposed to dry air (Burge 2004).

Description of the intervention

The humidity level of indoor air can be increased by:

  • Central or building‐level interventions that increase air humidity with air conditioning systems or whole‐house humidifiers;

  • Local or room‐level interventions, such as separate air humidifiers that can be activated on demand; or

  • Other interventions, such as putting plants around the workplace or placing a container of water or wet cloths in proximity to a radiator or a heating system.

Technically, air humidity can be regulated with different types of humidifiers: steam humidifiers produce vapour by thermal evaporation; cold atomisers atomise water with a high‐frequency ventilator; and the so‐called ultrasound‐atomisers create vapour by ultrasound waves (Fidler 1989). Re‐circulated water can be used, except for steam humidifiers. Overall, these different types of humidifiers use different techniques to increase air humidity. When aiming to humidify indoor air, we also need to consider the effects of natural ventilation and seasonal variations, as well as the influence on other factors of the indoor environment.

How the intervention might work

In order to achieve the recommended level of RH indoors and to prevent consequent dryness and irritation symptoms, workplaces and schools are being artificially humidified in some countries. There is, however, currently no clear evidence to advocate indoor air humidification.

The use of air humidifiers is often suggested to decrease the symptoms of dryness and irritation attributed to heating during winter, such as dry lips or eyes. This is a current opinion, but it has not been supported by all epidemiological and laboratory studies.

Various studies, predominantly conducted under controlled laboratory conditions, have evaluated the subjective symptoms related to different humidity levels, including objectively‐assessed signs and measurements of physiological parameters. Exposure to dry air may lead to ocular dryness due to deficient tear secretion and altered tear film (Lang 2014). According to Pfluger 2013, independent studies have shown that exposure to dry air causes deterioration in the quality and stability of the tear film of the eyes. These changes consequently result in an increase in eye blink frequency, which is one of the objective parameters measured in studies to assess the impact of dry air on ocular mucosa (Wolkoff 2008). Furthermore, there is a clear negative relationship between air humidity and evaporation (Pfluger 2013). A high evaporation rate reduces the quality of the tear film. These physiological changes in exposure to dry air may lead to ocular dryness symptoms which can be alleviated by an increase in the humidity level. There is experimental evidence that skin exposure to a low‐humidity environment affects the superficial skin layers and decreases their water content (Egawa 2002). Increasing humidity levels can mitigate skin dryness. Wyon 2006 concludes that the water content of the skin measured with a corneometer was significantly higher at a humidity level of 35% than at 15%.

Dehydration of the respiratory mucous membrane causes an increase in viscosity of the mucosal fluid and, as a consequence, ciliary clearance becomes less effective (Munkholm 2014). Elderly people, especially those living in nursing homes and staying in hospitals, seem to be more affected, since they cannot regulate their water fluid balance by themselves.

When looking at experimental evidence, studies in young populations have found that low humidity did not influence the mucociliary clearance (Andersen 1972Andersen 1974).

According to the findings of his experimental and clinical investigations, Guggenbichler 2007 concluded that mucociliary clearance seems to be more efficient when the humidity level is at least 30%. A relative humidity of 45% is even better for the self‐cleaning function of the airways. Water mist produced by several types of humidifiers reduces mucus viscosity (Arundel 1986).

Mucociliary clearance protects against bacterial and viral infection (Sahin‐Yilmaz 2011). Exposure to dry air results in the impairment of mucociliary clearance and leads to irritation of the mucous membrane, and as a consequence the susceptibility to infections may be increased. This hypothesis is controversial, since only a few studies with objective measurements have revealed pathophysiological damage to mucous membranes in the upper respiratory tract (URT) as a result of exposure to dry air. Alongside this direct effect of RH, the survival and transmission capacity of some respiratory viruses may be increased at a low level of absolute air humidity (Koep 2013Makinen 2009Shaman 2010). Overall, humidity and temperature affect host behaviour (more time spent indoors during winter time), host defences (airways mucosal function is optimal at core temperature and high humidity) (Williams 1996) and the stability and infectivity of the viruses. Furthermore, humidity also affects the respiratory droplet size, which in turn influences the time infectious particles remain airborne and can thus be inhaled.

Koep 2013 has shown that an increase in absolute humidity after humidification of the indoor environment resulted in a decreasing survival and transmission rate of the influenza virus. At a humidity level of more than 40% the influenza virus infectivity decayed (Tellier 2006). The surface of lipid‐containing viruses is supposedly inactivated at high atmospheric humidity levels (Shaman 2010). At high RH, large water‐laden droplets settle on the ground, which favours removal of infectious particles (Pica 2012).

During the recent pandemic of Covid‐19 (coronavirus disease 2019), there has been a concern of potential exposure to SARS‐Cov‐2 (severe acute respiratory syndrome coronavirus type 2) via airborne droplets, aerosols and contaminated surfaces (fomites) in workplaces and schools.There are various studies on the influence of the ambient temperature and relative humidity of coronavirus persistence in the air and on surfaces (Biryukov 2020Cheng 2020Moriyama 2020Otter 2016). Further research is needed to better understand these relationships.

Humidifiers and air conditioning systems can be a source of microbial spread, such as bacteria, fungi and amoebae, which can be disseminated into the air and cause health problems, such as infections and allergic reactions. In particular, facilities that are not sufficiently cleaned and maintained (Suva 2012) can be colonised with microorganisms. Furthermore, stagnant water in some humidifiers is linked to the so‐called 'humidifier lung' (a type of hypersensitivity pneumonitis) and so‐called 'humidifier fever' (a type of organic dust toxic syndrome).

In order to prevent pathogen growth, biocides are sometimes added to the water used for humidification. These substances may cause irritation or allergic reactions (Burge 2004) and even severe lung injuries, as presented in a number of papers (Won‐Young 2017).

As stated by the World Health Organisation (WHO), RH between 60% and 90% is favourable to the growth of mould, which is dependent on the growth medium, the mould species, the length of time in high relative air humidity and the measure of growth (WHO 2009).

The results from experimental and epidemiological studies are partially consistent. Conflicting findings among studies can be explained by the use of different clinical scores to assess the outcomes, by diverse study populations being exposed to different ranges of RH, different exposure assessments and different study designs (Pfluger 2013). The variability of the study results may also be explained by the absence (in most laboratory studies) or the presence (in studies conducted under real‐life conditions) of a wide range of different indoor air factors affecting skin and mucosal membranes. Some intervention studies have shown positive health effects of air humidification, like an increase in the percentage of people without dry and itchy skin (Hashiguchi 2008), alleviation of skin, pharyngeal, nasal dryness and congestion (Reinikainen 2003), significantly lower dryness symptom scores for skin and mucosa (Reinikainen 1992) and a reduction in the number and frequency of skin and mucosa symptoms (Ghaved 2005).

In summary, the effect of air humidity has been found to be dichotomised with a U‐shaped association. Both low and high RH levels (above 60%) are associated with respiratory symptoms, highlighting that adverse health outcomes may occur at both extremes of the relative air humidity scale. Whereas the latter might result in dryness and irritation of the mucosa and the skin (Reinikainen 2003), the former might be related to infections associated with airborne microbial contamination (Wolkoff 2007).

See Figure 1 for an explanation of the association of indoor RH with exposure to adverse health‐related factors by Alsmo 2014.

Why it is important to do this review

In Europe, recommendations on indoor relative air humidity differ between countries. In Switzerland, health authorities recommend at least 30% and a maximum of 65% RH to maintain a comfortable room climate (SECO 2011). However, there is no clear consensus on an optimal RH value, which may differ according to the working environment and the symptoms addressed. Concurrently, recommendations relating to the room temperature should be considered, since raising temperature leads to a decrease in RH. However, during heating periods, it is often not possible to achieve the recommended humidity range without active humidification. Further, acceptability of humidification may be of concern, because humidified air may be perceived to be of lower quality (Reinikainen 1997).

The question arises whether there is medical evidence behind the recommended RH range. In this context, Figure 1 is often shown, although its evidence base remains partially unknown. It seems questionable if it is generally possible to define a threshold at which physiological impairments occur, resulting in dryness and irritation symptoms of the skin and the mucous membranes that may consequently result in URT infections.

In countries with temperate or cold climates, air humidification is needed to reach an RH of 30% or more during the heating season. The use of air humidifiers is associated with significant costs, notably of electricity. However, if low humidity is associated with adverse health outcomes, this itself would generate direct and indirect costs, such as healthcare visits, absenteeism and reduced productivity.

A number of literature reviews have assessed the influence of humidity on human health (Arundel 1986Green 1979Guggenbichler 2007Mendell 1993Nagda 2001Pfluger 2013Pica 2012Von Hahn 2007Wolkoff 2007Wolkoff 2008Wolkoff 2018aWolkoff 2018b) whilst to date no systematic review on this topic has been published. Furthermore, we are not aware of any previous Cochrane Review that overlaps with this review. There is consequently an urgent need to compile the available evidence about health effects associated with air humidification amongst workers and in educational settings. Evidence has been accumulated over the past decades, and it is important to integrate evidence originating from epidemiological (field) studies. One challenge may be to include older evidence, generated decades ago, as well as to target different populations and settings, including children.

See Figure 2 for an explanation of the structure of our systematic review and relevant factors for the indoor environment.


Description of this Cochrane review. URT = upper respiratory tract.

Description of this Cochrane review. URT = upper respiratory tract.

Objectives

To evaluate the effectiveness of interventions that increase indoor air humidity to prevent or reduce dryness symptoms of the eyes, the skin and the upper respiratory tract (URT) or URT infections at work and in educational settings.

Methods

Criteria for considering studies for this review

Types of studies

Because we expected that the effect of indoor air humidification on symptoms would be rapid and would also disappear quickly after the intervention has stopped, we included cluster‐randomised and cluster non‐randomised cross‐over studies.

Because humidification of the air is an intervention that usually takes place at a group level and is provided outside the clinical setting, randomisation at the individual level is scarcely possible.

We therefore included the following study types:

  • Cluster‐randomised and cluster non‐randomised cross‐over studies

  • Controlled before‐after studies, where the outcome is measured in both the intervention and the control group twice, once before and once after the intervention

  • Interrupted time‐series studies, where outcomes are measured at least three times before the intervention and three times after the intervention

  • Controlled studies with parallel‐group design (referred to as 'quasi‐randomised studies, where the method of randomisation is not truly random, such as alternation' in the study protocol)

Types of participants

We included studies conducted in:

  • Adults (18 years or older) working in buildings in any occupational sector and in any professional activity

  • Children (preschool and school‐age children in an educational setting (kindergarten/pre‐school/nursery school, daycare centres, primary school)) and adolescents and young adults (up to a maximum age of 30) in an educational setting (college, high school/university)

If only a subset of relevant participants were included in a study, we included this study in the review if minimal data for this group could be extracted, including data about the intervention and the control group. We made it clear to the reader that the included data were only a subset of the study. We included both studies that could be considered preventive because participants were free of symptoms at the start of the study and had not requested any intervention, and studies that could be considered as remediation because participants complained of symptoms and had requested measures to improve their symptoms.

Types of interventions

We included studies evaluating the effectiveness of any type of intervention aiming to increase indoor air humidity. We categorised interventions as follows:

  • Central or local indoor air humidification, i.e. air conditioning with humidification at building level (central), or stand‐alone humidifying devices at room level (local)

  • Other interventions, such as putting plants around the workplace

We included studies that compared the effects of indoor air humidification to no intervention or an alternative intervention.

Technically, air humidity could be regulated with different types of humidifiers: steam humidifiers produce vapour by thermal evaporation, cold atomisers atomise water with a high‐frequency ventilator and the so‐called ultrasound atomisers that create vapour by ultrasound waves (Fidler 1989).

To be included in this review, a study had to specify absolute or relative air humidity estimates of the intervention and the control areas or settings.

Types of outcome measures

We included studies that reported at least on one of our primary outcomes. We used data from additional outcomes reported in included studies if they were part of our secondary outcomes.

Primary outcomes

  • Eye symptoms: self‐reported eye symptoms, such as dry eyes, itching eyes, other physical symptoms of the eye, or objectively‐measured outcomes such as the blinking rate

  • Skin symptoms: self‐reported skin symptoms such as a dry or itching skin or objectively‐measured by e.g. a corneometer

  • Upper respiratory tract (URT) symptoms and health conditions related to the quality of the mucosa, such as dry nose, nose symptoms, dry mouth, dry throat, pharyngeal dryness, and health impairments, such as rhinitis, rhinosinusitis, the common cold, sore throat, hoarseness, cough, throat inflammation or irritation, laryngitis, tonsillitis and otitis media, as self‐reported or physician‐diagnosed conditions or objectively‐measured physiological signs (by means of acoustic rhinometry and nasal lavage)

Secondary outcomes

  • Perceived air quality: air dryness, stuffy air, or a general assessment of air quality

  • Sick leave or absence from work, school or education, measured as episodes or duration

  • Task performance, productivity and attendance

  • Costs of the intervention to increase indoor air humidity

  • Adverse effects

Since effects of indoor air humidity on symptoms and infections might be observed after very short (days) as well as longer time periods (months), we intended to consider the following time scales:

  • Up to one month;

  • Between one month and three months (one season); and

  • Longer than three months, covering several seasons.

Exclusion criteria

This focus allowed us to detect specific seasonal patterns with indoor heating and non‐heating periods that could also impact and contribute to dryness symptoms of the mucosa. We therefore excluded studies conducted in buildings situated in tropical and subtropical climates, to avoid mixed climatic patterns.

If data were available, we distinguished between allergic and non‐allergic symptoms and illness, and excluded the former.

Search methods for identification of studies

Electronic searches

In order to identify all published and unpublished trials that could be considered eligible for inclusion in this review, we conducted a systematic literature search. We adapted the Ovid MEDLINE search strategy proposed in Appendix 1 to the additional databases: Embase (Appendix 2), CENTRAL (Appendix 3), PsycINFO (Appendix 4), Web of Science (Appendix 5), Scopus (Appendix 6), NIOSHTIC‐2 (Appendix 7), HSELINE and CISDOC (Appendix 8). Sensitivity and precision of the search strategy had to be balanced. Our approach was based on sensitivity in order to be able to identify the relevant information. Our search included: a) the intervention and application methods used; b) targeted physiological systems and related symptoms, syndromes, infections and illness; c) effects on occupational or educational attendance; and d) workplace and educational settings in general and specific ones. We did not include the study design in our search strategy, as we expected different terminologies to be used during the past decades. We targeted this aspect within the screening process.

We included studies published as full text, abstracts as well as unpublished results, and we considered studies in all languages.

Our most recent searches were performed in 2020, and we conducted electronic searches within the following databases:

Health/biomedical

  • Ovid MEDLINE with available non‐indexed citations (1946 to 04 December 2020)

  • Embase (1947 to 04 December 2020)

  • CENTRAL (Cochrane Library up to 04 December 2020)

  • PsycINFO (1806 to 04 December 2020)

We did not perform searches in PsycArticles or Psyndex.

Occupational safety and health

  • NIOSHTIC‐2 (from inception to 09 December 2020)

  • HSELINE (from inception to 15 November 2016)

  • CISDOC (from inception to 15 November 2016)

  • In‐house database of the Division of Occupational and Environmental Medicine, University of Zurich and University Hospital Zurich. This database results from a manual search in the Current Contents Life Sciences and the main journals of occupational and environmental health. It includes more than 50 journals related to occupational and environmental health, internal medicine, epidemiology, nephrology, and toxicology, and covers the period from 1986 to December 2013)

Interdisciplinary

  • Web of Science (1988 to 04 December 2020)

  • Scopus (1960 to 04 December 2020)

Searching other resources

We conducted a search of unpublished or ongoing trials in the WHO trials portal (www.who.int/ictrp/en/; up to 31 October 2019) as it collated data on trials from different countries including the USA CDC. In addition, we carefully checked the reference lists of included studies and of relevant reviews for additional eligible studies.

We searched publications from the websites of governmental agencies, such as the Centers for Disease Control, the National Institute for Occupational Safety and Health (NIOSH), and the American Society of Heating, Refrigerating and Air‐Conditioning Engineers (ASHRAE).

We contacted occupational medicine and health specialists for additional references and grey literature. Where necessary, we asked for data from authors.

Data collection and analysis

Selection of studies

After removal of duplicates, two review authors (from KB, DI, MM, MS, MP or TR) independently screened titles and abstracts for inclusion. If necessary for the decision process, we read full texts, e.g.in cases where no abstracts were available. We resolved inconsistencies or disagreements through discussion and by consultation with other review authors (MP, MM, HD) where necessary. We carefully recorded the study selection process in order to complete the PRISMA flow diagram and the Characteristics of excluded studies table (Liberati 2009). Data included covered the study design, the participants, the type and technique of the intervention, the outcome measures and a final assessment for inclusion. We used Covidence for study screening and data extraction.

The screening and assessment of studies identified through systematic searches that were conducted by authors of this review was done by review authors who were not involved in the study.

Data extraction and management

We used a data collection form for study characteristics and outcome data, shown in Appendix 9, which had been piloted on two studies. Two review authors (KB, DI) extracted study characteristics from included studies. A second author (from HD, MM or TR) reviewed a random selection of data collection forms for accuracy and completeness.

We extracted the following study characteristics if available:

  • General and context information: study identifier (ID), report ID, citation, year of publication, first author, contact author, affiliation, country, funding information, conflict of interest (declared and if appropriate, suspected (e.g. coworker of a relevant company)), environmental factors: season, urban or rural, type of the building, facility type.

  • Methods: aim(s) and objective(s) of the study, study design, total study duration, study location, date of study, sample size considerations and power calculation, statistical analyses, withdrawals, and dealing with missing data.

  • Participants: number of people included, selection procedure, participation, representativeness, inclusion criteria, exclusion criteria, study setting, professional activity, mean age or age range (median, percentiles), sex/gender, sociodemographic characteristics (e.g. smoking status, alcohol intake, socio‐economic level, comorbidities, medication, atopy, family history).

  • Interventions: types/description/content of intervention and comparison (including type of humidification), time period of intervention and comparison, duration of intervention and comparison, intensity of intervention and comparison, co‐interventions, economic information. Assessment of air humidity level, control humidity level, recorded outdoor and indoor climatic parameters (e.g. temperature).

  • Outcomes: definition/criteria and description of primary and secondary outcomes specified and collected, and at which time points reported or measured or both, source of outcome criteria, person measuring/reporting, outcome measurement (subjective: self‐reported questionnaire (scales), interview (explanation to the participants), objective: physiologic measurements), severity of condition, diagnostic criteria if applicable, validation of outcome tools.

  • Results: humidity effects (self‐reported, results of scales and/or measured by physiological tests), adjusting for potential confounders.

Two review authors (from KB, DI or KB, TR) independently extracted outcome data from included studies. We noted in the Characteristics of included studies table if outcome data were not reported in a usable way. We resolved disagreements by consensus or by involving a third review author (from HD, MM, MS, MP, TR). One review author (from KB, DI, TR) transferred data into Covidence and then transferred them to the Review Manager 5 (RevMan 2020) file. We double‐checked that data were entered correctly by comparing the data presented in the systematic review with the study reports. A second review author (from HD, MM, TR) spot‐checked study characteristics for accuracy against the trial report. Following the decision to include studies in any language, we asked a native speaker to provide translations in case our author team was not proficient.

Assessment of risk of bias in included studies

Following pilot‐testing to calibrate the assessments by KB, TR, DI, HD, MM, MP, MS, two review authors (from KB, DI or TR) independently assessed the risks of bias of all included studies. We resolved disagreements through discussion and consulted another author (from MM, MS, MP, HD) where necessary.

We used the Cochrane standard risk of bias (RoB) tool to assess the risks of bias in controlled studies.

We used the following items to assess the risk of bias in randomised controlled studies:

  • Sequence generation

  • Allocation concealment

  • Blinding of participants or organisations if applicable, and outcome assessors

  • Incomplete outcome data

  • Selective outcome reporting

  • Control for confounders

We have decided to use an additional item: 'Other source of bias'.

We assessed non‐randomised controlled studies according to the following items:

  • Blinding of participants or organisations if applicable, and outcome assessors

  • Incomplete outcome data

  • Selective outcome reporting

  • Other source of bias

  • Control for confounders

In the case that self‐reported questionnaires were used in original studies, judgement on blinding of participants or organisations, and outcome assessors is not applicable.

For cross‐over studies, we additionally applied the questions suggested for assessing the risk of bias from the Cochrane Handbook for Systematic Reviews of Interventions (Chapter 23):

  • Was use of a cross‐over design appropriate?

  • Is it clear that the order of receiving treatments was randomised?

  • Can it be assumed that the trial was not biased from carry‐over effects?

  • Are unbiased data available?

For each of these items, we provided one of the following summary assessments:

  • Low risk of bias: plausible bias unlikely to alter the results.

  • Unclear risk of bias: plausible bias that raises some doubt about the results.

  • High risk of bias: plausible bias that seriously weakens our confidence in the results.

To judge risk of bias in randomised controlled studies as well as interrupted time series, we used the criteria proposed by EPOC 2015, as well as criteria from the Cochrane Handbook. For the additional item 'control for confounders', we first judged if there were important differences between groups prior to the intervention according to predefined confounders. If yes, we assessed whether these relevant confounders were controlled by means of study design (e.g. randomisation, restriction, matching) or as part of data analysis (e.g. stratification, statistical modelling). We considered the risk of bias to be low if there were no important differences between groups or if 60% or more of the relevant confounders were controlled in the assessed study. Otherwise, we classified the domain as 'high risk of bias'. We applied a rating of 'unclear risk' if the information was insufficient or lacking. The relevant confounders that we considered for this review included season (outdoor air), personal characteristics (e.g. age, gender), co‐morbidities, atopic conditions and co‐exposure in the workplace or in the educational setting.

We summarised the risk of bias within and across studies for the primary outcomes and for absenteeism.

We considered confounding, blinding of participants and outcome assessors and incomplete outcome data to be key domains. We judged a study to have a high risk of bias when one or more key domains were rated as being at high risk of bias. Conversely, we judged a study to have a low risk of bias when we judged low risk of bias for all key domains. We summarised the risk of bias judgments across different studies for each of the domains listed.

We summarised and presented data in a risk of bias summary together with a risk of bias graph, as described in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011).

Assessment of bias in conducting the systematic review

We conducted the review according to the published protocol and reported any deviations from it in the Differences between protocol and review section.

Measures of treatment effect

We analysed data separately from studies involving working populations and from studies involving children.

We reported the absolute or relative indoor air humidity as continuous variables.

We entered the outcome data for each study into the data tables in RevMan (RevMan 2020) to calculate the intervention effects. We used odds ratios (ORs) for dichotomous outcomes, mean differences (MDs) or standardised mean differences (SMDs) for continuous outcomes, and other types of data as reported by the authors of the studies. The reported outcome data were presented as percentages of participants affected and were transformed into the number of events. For the cross‐over trials with dichotomous data, we computed the pooled logarithm of the OR (InOR) based on the usual weighted average of trial InOR where weights are the inverse of the InOR variance. This method is described by Elbourne 2002. The InORs were transformed to ORs in RevMan. Furthermore, we included statistical approaches available which re‐expressed odds ratios as standardised mean differences (and vice versa), allowing dichotomous and continuous data to be pooled together. We did this as proposed in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011) and after consultation with a biostatistician. In the case that multiple analyses were conducted in a study, review authors agreed on which of these were most relevant for the review.

Unit of analysis issues

If in future versions of this review we come across studies that use a cluster‐randomised design and that report sufficient data to be included in the meta‐analysis but do not make an allowance for the design effect, we will calculate the design effect based on a fairly large assumed intra‐cluster correlation of 0.10, as described in the protocol (Byber 2016).

Dealing with missing data

We contacted investigators in order to verify key study characteristics and obtain missing numerical outcome data where possible (e.g. when a study was identified as abstract only). If in future updates of this review we come upon studies where this is not possible, and the missing data are thought to introduce serious bias, we will explore the impact of including such studies in the overall assessment of results by a sensitivity analysis.

We could not extract data from one study (Enomoto‐Koshimizu 2002). The authors conducted a controlled before‐after study, but they reported data for the intervention and control groups together. In order to gather details for the two groups separately, we contacted the authors. They made great efforts, but in the light of the elapsed time since the study was conducted, study data could not be extracted. Hence, we included this study, but study data could not be reported and assessed in this review.

The data from Gavhed 2005, a cross‐over study design, were analysed as a parallel design. We asked the authors for primary data and could extract the effects for the first study period only. In a subsequent assessment we modelled all possible paired tables comparing questionnaires 2 and 3. The odds ratios were based on McNemar's test. We then chose the option close to the one calculated in the first study period and reported these data.

Similarly, if in future updates of this review we come upon studies where numerical outcome data, such as standard deviations or correlation coefficients are missing, and cannot be obtained from the authors, we will calculate them from other available statistics such as P values, according to the methods described in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011).

Assessment of heterogeneity

We assessed the clinical homogeneity of the results of included studies based on the similarity of the population, intervention, outcome and follow‐up.

We considered populations as similar when they belong to the same subgroup (working adults or children in education).

We considered outcome measurements as similar enough to combine when:

  • Subjective symptoms were assessed (stratified by symptom group: eye, skin, URT, combined), and when

  • Objective measurements were performed (stratified by target organ: eye, skin, URT, combined).

We considered interventions as similar when they included indoor air humidification with:

  • An air conditioning system (centrally‐located system), or

  • Local, office‐based humidifiers, or

  • Other measures to increase indoor air humidity, such as for instance putting plants around the workplace, or placing a container of water or wet cloths in proximity to a radiator or a heating system.

Following the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011), we used the I2 statistic to measure heterogeneity among the trials in each analysis. As we pooled up to a maximum of two studies, after identification of substantial heterogeneity we could not explore possible causes by prespecified subgroup analysis. We narratively described the heterogeneity related to the different methods used. If future updates allow measuring of heterogeneity we will proceed and interpret as described in the protocol (Byber 2016).

Assessment of reporting biases

We were unable to pool more than five trials in a single meta‐analysis. Hence, we did not create a funnel plot to explore possible small‐study biases.

Data synthesis

We present the characteristics and methods of included studies in the summary tables. We pooled data from studies with the same study design related to the same outcome. As the evidence was considered to be too heterogeneous to conduct meta‐analyses, we synthesised evidence narratively.

Subgroup analysis and investigation of heterogeneity

If future versions of this review find a sufficient number of studies, we plan to undertake subgroup analyses by professional activity (office workers compared to non‐office workers, e.g. healthcare workers in hospitals), and by gender as described in the protocol (Byber 2016).

Sensitivity analysis

We did not perform sensitivity analysis because there were not a sufficient number of studies. If future versions of this review find a sufficient number of studies, we will perform sensitivity analysis defined a priori to assess the robustness of our conclusions, as described in the protocol (Byber 2016).

Reaching conclusions

We based our conclusions only on findings from the quantitative or narrative synthesis of included studies for this review. We avoided making recommendations for practice based on more than just the evidence, such as values and available resources. Our implications for research suggest priorities for future research and outline what the remaining uncertainties are in the area.

Summary of findings and assessment of the certainty of the evidence

We created summary of findings tables using the outcomes of eye, skin and upper respiratory tract (URT) (nose) symptoms, measured as self‐reported symptoms or conditions. We used the five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence as it relates to the studies which contribute data to the meta‐analyses for the prespecified outcomes. We used methods and recommendations described in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011). All decisions to down‐ or upgrade the quality of studies were justified using footnotes, and we added comments to support readers' understanding of the review decision where necessary.

We present the data for the two subgroups separately: working adults and children in education.

We graded the evidence yielded by each comparison as one of the following:

  • High quality — further research is very unlikely to change our confidence in the estimate of effect;

  • Moderate quality — further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate;

  • Low quality — further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate;

  • Very low quality — any estimate of effect is uncertain

Results

Description of studies

See Figure 3, Characteristics of included studies, and Characteristics of excluded studies. No studies await classification, and no or ongoing studies were identified.


Study flow diagram.

Study flow diagram.

Figure 3

Results of the search

Based on our searches, we screened 12,230 references from electronic databases, and one study from other sources. The last search was run in December 2020, which updated previous searches in June 2016 and 2017 and August 2019. Based on title and abstract and, if unavailable, referring to the full text, a total of 230 references entered the full‐text screening. This resulted in 13 studies to be included in the data extraction process and 192 studies were excluded after removing of duplicates (see Excluded studies). Handsearching of the reference lists did not yield additional studies.

Included studies

Study types

Occupational setting

We initially found eight studies conducted in the occupational setting and comprising office (three studies), factory (one study) and hospital workers (four studies). The data for one study (factory study) could not be extracted, as the data reported did not match our data extraction requirements (Enomoto‐Koshimizu 2002).

Findings of seven studies were therefore reported, with three controlled before‐after studies (Hashiguchi 2008Norbäck 2000Nordström 1994) and three controlled cross‐over studies (Gavhed 2005Reinikainen 2003; with one cluster‐randomised cross‐over design (Reinikainen 1992)). Here, the unit of randomisation was the office section (in two wings) of the building, randomly assigned at the beginning of the study (Reinikainen 1992). One study used a non‐randomised controlled parallel‐group design (Green 1981).

Educational setting

Five studies targeted an educational setting and were designed as non‐randomised controlled parallel‐group studies (Green 1975Reiman 2018Ritzel 1966Sale 1972Sataloff 1963).

Participants

Occupational setting

A total of 3422 office and hospital workers were reported as participants, of whom 3160 (92%) were included in the data analyses. No age‐related information was given in the studies of Green 1981 and Reinikainen 2003. The ages of the study populations of Hashiguchi 2008Norbäck 2000 and Nordström 1994 were as follows: Hashiguchi 2008: mean 40.1 years (± 10 standard deviation (SD)) in the intervention and mean 38.7 (± 11.5 SD) in the control group; Norbäck 2000: mean 39 (± 10 SD) in the intervention group and mean 44 (± 12 SD) in the control group; Nordström 1994: mean 40 years (± 13 SD) in the intervention and mean 38 (± 9 SD) in the control group (at the end of the study). Regarding Gavhed 2005 and Reinikainen 1992, a wider age range was described (see Characteristics of included studies). The population in the studies of Hashiguchi 2008Norbäck 2000; and Nordström 1994 included predominantly women, whereas in Reinikainen 1992 there were almost half women and men. No gender‐related information was presented in Gavhed 2005Green 1981, and Reinikainen 2003.

Educational setting

Studies conducted in the educational setting included kindergarten and school children. No study mentioned the number of participants in the intervention and the control groups. Three studies did not report the number of individuals that entered the analyses (Green 1975Ritzel 1966Reiman 2018), but indicated the total school days per group (Ritzel 1966Reiman 2018). The two remaining studies included 222 children in the intervention and 203 in the control group in the analyses (Sataloff 1963Sale 1972). Sataloff 1963 provided no age information for the participants. Reiman 2018Ritzel 1966 and Sale 1972 included children at preschool age (2 ‐ 5, 4 ‐ 6, 2½ ‐ 6 years of age, respectively) and the pupils in the study of Green 1975 were aged between six and 14 years. None of the studies reported the gender distribution.

Sample size

Occupational setting

Three studies (Gavhed 2005Norbäck 2000Hashiguchi 2008) conducted in the occupational setting had very small sample sizes, below 50 participants (39, 32, 45) and a further three studies (Nordström 1994Reinikainen 1992Reinikainen 2003) reported fewer than 550 participants (104 (dynamic population), 290, 517). In Green 1981 the number of participants exceeded 2000 (2395), but with only 185 participants in the intervention group. The data for participants entering the data analysis are provided in Characteristics of included studies and the summary of findings tables. No sample size or power calculations were reported.

Educational setting

The number of study participants ranged between 116 and 515 (116, 232, 515, 162) (Reiman 2018Ritzel 1966Sale 1972Sataloff 1963) and one study only reported that 12 schools with children of grades 1 to 8 were included (Green 1975). The number of participants entering the data analysis is provided in Characteristics of included studies and the summary of findings tables. No sample size or power calculations were reported.

Year of publication and geographical location

Occupational setting:

These studies were published between 1981 and 2008, with three articles before 2000 and four between 2000 and 2008. They were conducted in Canada (1), Finland (2), Japan (1), and Sweden (3).

Educational setting:

These articles were published between 1963 and 1975 and in 2018. The studies were performed in Canada (1), Switzerland (1), and the USA (3). The Swiss study was published in German.

Exposure and co‐exposure

All the included studies assessed relative indoor air humidity as an indicator for dry air. In most studies, humidity was recorded continuously during the whole or parts of the study period. In one study (Gavhed 2005), the method of exposure assessment was not reported, and values of absolute humidity were mentioned in three studies (Reiman 2018Reinikainen 2003Hashiguchi 2008). The levels of relative humidity in the included studies varied considerably and the measured values were stated as a range, a mean value with or without standard deviation or as an unspecified value. The differences between humidity levels in the control and intervention groups were also heterogeneous. In most of the studies there were only small differences (less than 10% in humidity levels between humidified and un‐humidified conditions) or the relative humidity in both conditions overlapped (Nordström 1994Reinikainen 1992Reinikainen 2003Reiman 2018Sale 1972Sataloff 1963). The differences between humidity levels were analysed in one study and there were important differences in humidity levels between groups (Nordström 1994). An obvious difference (more than 10% difference in humidity levels) was reported in Gavhed 2005 and Reiman 2018. In all studies temperatures for both conditions were stated, and in 10 of the 12 studies the temperature levels were almost the same in the intervention and control setting (Gavhed 2005Green 1975Hashiguchi 2008Norbäck 2000Nordström 1994Reiman 2018Reinikainen 1992Ritzel 1966Sale 1972Sataloff 1963). All studies were conducted during the heating period.

Occupational setting

In some occupational studies co‐exposure was assessed. In Norbäck 2000 and Nordström 1994 volatile organic compounds were measured, and Reinikainen 2003 assessed the formaldehyde concentration. Nordström 1994 and Reinikainen 2003 additionally assessed particle concentration. Biological exposure to bacteria and fungal spores was measured in Reinikainen 2003 and Reinikainen 1992, and they also mentioned the ventilation rates. In all these studies the co‐exposure seemed to be at low levels or within reference ranges and therefore an influence on developing or increasing dryness symptoms of the skin, eye and upper respiratory tract was not considered.

Educational setting

The most recent study conducted in the educational setting (Reiman 2018) assessed particles as co‐exposure. The average concentration and size of particles in both conditions were measured, with 96% of the particles provided by humidification less than 1 μm. Humidified rooms showed a near doubling of both 1 ‐ 4 μm, and > 4 μm air particles. There was a significant increase in the population of larger‐sized particles (1 – 4 μm and > 4 μm) in the humidified versus control rooms. The other studies in the educational setting did not assess further co‐exposure factors, except for temperature (Green 1975Ritzel 1966Sale 1972Sataloff 1963).

Interventions and comparisons

Each study evaluated one intervention: the effect of indoor air humidification.

Intervention in the occupational setting

In four studies (Gavhed 2005Green 1981Norbäck 2000Nordström 1994) central humidification was conducted, and in three trials (Hashiguchi 2008Reinikainen 1992Reinikainen 2003) local humidification. Mostly, steam humidifiers were used. No study was dealing with other interventions (such as putting plants around the workplace or placing a container of water or wet cloths in proximity to a radiator or a heating system).

Intervention in the educational setting

Most studies used only local humidification (Reiman 2018Ritzel 1966Sataloff 1963), and one study reported central humidification (Sale 1972). Various types, such as steam humidifiers, water atomizers, spray cold humidifiers, air washers and boilers were used in one study involving 12 different schools (Green 1975). No study was using other interventions.

Study duration

Occupational setting

In the occupational setting, the study duration ranged from six weeks (Norbäck 2000Reinikainen 1992Reinikainen 2003) to seven months (Green 1981), including eight weeks (Gavhed 2005), 12 weeks (Hashiguchi 2008) and five months (Nordström 1994). Green 1981 was conducted during three seasons. In order to investigate effects of indoor air humidity on symptoms and infections after very short (days) and longer time periods, we initially intended to establish three groups using three time scales (up to one month, between one and three months, longer than three months). Our data did not allow us to undertake such subgroup analyses.

Educational setting

In the educational setting, the study duration ranged from seven weeks (Reiman 2018) to six months (Green 1975). One study (Green 1975) presented additional data over a time period of 10 years.

Control

Occupational setting

Three studies (Gavhed 2005Reinikainen 1992Reinikainen 2003), all comprising office workers, described a cross‐over design with a control group.

In the remaining four studies (Green 1981Hashiguchi 2008Norbäck 2000Nordström 1994), the control group consisted of hospital employees. Green 1981 used two control groups, which worked in two different non‐humidified hospitals. In this trial, the number of participants in the control site was disproportionate higher than in the intervention site (n = 650 in one control group, n = 1560 in the second control group versus 185 in the intervention group). The intervention group was stationed in the third hospital building, which was humidified. In Hashiguchi 2008 and Norbäck 2000, the control and intervention group participants worked in the same building, but in different stations and units, respectively. Nordström 1994 was conducted in four units in two hospitals. Two randomly‐selected units, one per hospital, served as intervention and control sites, respectively.

Educational setting

Green 1975 was conducted in 12 primary schools. The control group included four non‐humidified buildings and also non‐humidified classes in another school. The control group of Ritzel 1966 were located in five non‐humidified kindergartens, and the intervention group in five nearby kindergartens. In Sale 1972, there was no clear control group. For the purposes of the analysis, we combined a group consisting of children who were not exposed to humidified air with the group of children exposed to humidified air at home only. Reiman 2018 and Sataloff 1963 were conducted in one building, where some classes were humidified and others were not.

Outcomes and outcome assessment

Occupational setting

Primary outcomes

Primary outcomes were investigated in only six of the seven studies in the occupational setting (Gavhed 2005Hashiguchi 2008Norbäck 2000Nordström 1994Reinikainen 1992Reinikainen 2003). Different outcome definitions were used for the assessment of symptoms related to the location. We established groups of similar symptoms according to the targeted location.

Almost all studies used self‐administered questionnaires to survey symptoms. In Hashiguchi 2008 interviews with staff members about their symptoms were carried out once a week. In all studies, the symptoms and conditions were not assessed or diagnosed by a physician.

Two studies, (Norbäck 2000Nordström 1994) referred to a standardised questionnaire for assessing symptoms, the MM‐040‐NA questionnaire. This validated instrument was developed at the Department of Occupational and Environmental Medicine, Örebro University Hospital in Sweden. As it was established as an exploratory questionnaire aiming to assess the sick building syndrome and no test statistics were mentioned, we left it unconsidered as a reference questionnaire for assessing work‐related dryness symptoms. Furthermore, there were indications that Nordström 1994 and Norbäck 2000 used modified versions of MM‐040‐NA (different number of questions, different scoring).

The questionnaire used by Norbäck 2000 comprised seven questions about eye irritation (one question), airway symptoms (three questions) and dermal symptoms (three questions). The prevalence of participants with at least one weekly symptom of the eyes, airway, and skin was determined. Raw ORs were adjusted for age, sex, atopy, smoking habits, employment time, type of occupation, and psychosocial work climate. We entered the number of events into RevMan and computed unadjusted ORs for comparability. The prevalence of participants with at least one weekly symptom of the eyes, airway, and skin was calculated in Nordström 1994.

Reinikainen 1992 used one weekly symptom diary, in order to record symptoms in the humidified and non‐humidified conditions. For data collection, Reinikainen 2003 used a structured diary which the participants filled in every afternoon. Strong symptoms were coded as 3 and no symptoms as 0. Gavhed 2005 used a self‐administered questionnaire with a five‐point Likert scale which was filled in once a week. For the analysis, we pooled the frequency responses 'seldom and never'; 'daily, many times a week', 'few times a week'. The data were transformed to ORs in RevMan.

In Norbäck 2000, there was an additional objective measurement of the outcomes (see below).

Eye symptoms

Five studies evaluated the effect of humidification on eye symptoms: three cross‐over studies (one RCT: Reinikainen 1992 and two non‐RCTs: Reinikainen 2003Gavhed 2005) and two before‐after studies (Nordström 1994Norbäck 2000). Reinikainen 1992 investigated eye symptoms described as 'dryness, irritation and itching'. Reinikainen 2003 used the term 'eye dryness', without listing more details, and Gavhed 2005 additionally used the terms 'itching' and 'burning' for describing dry eyes. Nordström 1994 defined eye symptoms as 'itching, burning, or irritation in the eyes' and Norbäck 2000 evaluated eye symptoms summarised as 'burning, dry, sore eyes, eye redness, swollen eyelids'.

Objective measurements were applied in one study (Norbäck 2000). Clinical signs of the eyes were rated by assessing tear‐film stability: “a standardised method, measuring the time (tear film breakup time) the subject could keep the eyes open without pain, when watching a fixed point at the wall”.

Skin symptoms

Two cluster non‐randomised cross‐over studies (Reinikainen 2003Gavhed 2005) and two before‐after studies (Hashiguchi 2008Nordström 1994) investigated 'dry skin' as an outcome (summary of findings Table 1). Norbäck 2000 evaluated the following skin symptoms: facial itching, facial rash, itching on the hands, rash on the hands, or eczema, whereas Reinikainen 1992 defined skin symptoms as dryness, irritation and itching.

Gavhed 2005 used a self‐administered questionnaire assessing the frequency of 'dry skin' symptoms once a week on a five‐point Likert scale. For the analysis, we pooled the answers 'seldom' and 'never'; 'daily', 'many times a week', 'few times a week'.

Hashiguchi 2008 used a four‐point scale for reporting the frequency of dry and itchy skin: 'none', 'rarely', 'sometimes' and 'frequently'. We pooled the responses for 'rarely', 'sometimes' and 'frequently' for the purposes of our review, and treated the group 'none' separately.

Upper respiratory tract (URT) symptoms

Five studies evaluated the effect of humidification on upper respiratory tract symptoms: three cross‐over studies (one RCT: Reinikainen 1992 and two non‐RCTs: Reinikainen 2003Gavhed 2005) and two before‐after studies (Nordström 1994Norbäck 2000). Different symptoms and location of the symptoms were investigated: Reinikainen 2003 and Reinikainen 1992 evaluated dry nose and pharyngeal dryness. Gavhed 2005 used 'dry mouth and throat' as an outcome with a five‐point Likert scale for the frequency of symptoms ('never', 'seldom', 'daily', 'few times a week', 'many times a week'). For this review, the points 'seldom' and 'never' as well as 'daily', 'many times a week', 'few times a week' were put together. In Norbäck 2000 the throat symptoms were defined as dryness in the throat, sore throat, irritative cough (not shown), and nose symptoms such as runny nose, nasal itching, sneezing, or nasal obstruction. Nordström 1994 summarised the airway symptoms as irritated, stuffy or running nose, hoarse or dry throat, or cough.
In addition, Norbäck 2000 measured nasal signs by acoustic rhinometry. As parameters, the minimum cross‐sectional areas (MCA) and the volumes of the nasal cavity (VOL) on each side of the nose were measured. The mean of three subsequent measurements was calculated. Furthermore, the concentrations of the following biomarkers: eosinophilic cationic protein (ECP), myeloperoxidase (MPO), albumin, and lysozyme were measured in the nasal lavage.

Upper respiratory tract (URT) infections

Symptoms of irritation, infection and allergy in the upper respiratory tract might overlap, which made their differentiation challenging. No studies investigated upper respiratory tract infections directly, which means that the diagnosis of this condition was not assessed as an outcome. Symptoms related to airway infection were investigated in Gavhed 2005Norbäck 2000Nordström 1994Reinikainen 1992Reinikainen 2003 (see above).

Of these studies, only Reinikainen 2003 mentioned an assessment of symptoms of upper respiratory infection. They stated that the applied diary comprised questions about symptoms of upper respiratory infection. These symptoms were analysed separately and no conclusion was drawn on the effect of indoor air humidification on upper airway infections.

Secondary outcomes

Perceived air quality

Perceived air quality was investigated in the following studies: Hashiguchi 2008Norbäck 2000Nordström 1994Reinikainen 1992Reinikainen 2003. Perception of dryness was assessed in five studies: one non‐RCT cross‐over study (Gavhed 2005), one RCT cross‐over study (Reinikainen 1992) and three before‐after studies (Hashiguchi 2008Norbäck 2000Nordström 1994). Perception of stuffiness was analysed in four studies: one non‐RCT cross‐over study (Reinikainen 2003), one RCT cross‐over study (Reinikainen 1992) and two before‐after studies (Norbäck 2000Nordström 1994).

Nordström 1994 calculated changes in dryness perception and perception of stuffiness for each individual (range of the scale −2 to 2) at the beginning and end of the study period. The results were presented as incidence of decreased and increased perception. The changes after four months were presented, but the baseline data were unavailable. To achieve a comparison to Norbäck 2000, we recoded the reported levels of changes in participants' perceptions (i.e. increased, unchanged, decreased) into numerical variables (i.e. 0 = decreased, 1 = unchanged, 2 = increased). We transformed these data into means with standard deviations, and computed standardised mean differences in order to express the size of the intervention effect. The participants in Norbäck 2000 subjectively rated air quality (air dryness and stuffy air) on a scale between 0% to 100% at the beginning and the end of the study period in the humidified group and controls. We took the values at the study end in order to calculate the standardised mean difference. We pooled the computed values of Norbäck 2000 and Nordström 1994.

Gavhed 2005 used a self‐administered questionnaire with a five‐point frequency scale including 'too dry', 'slightly dry', 'neutral', 'slightly moist' and 'too moist'. For the analysis, we pooled the levels 'too dry, slightly dry', 'neutral' and 'slightly moist, 'too moist', respectively.

Hashiguchi 2008 used a seven‐point frequency scale for reporting the perception of dryness, with 'very dry', 'dry', 'slightly dry', 'neutral', 'slightly damp', 'damp' and 'very damp'. We pooled the results into two categories. The responses to 'very dry', 'dry' and 'slightly dry' were than compared with those of 'neutral', 'slightly damp', 'damp' and 'very damp'.

Absence from work

In the occupational setting only Green 1981 assessed absenteeism.

Educational setting

Primary outcomes

No studies conducted in educational settings investigated our primary outcomes.

Secondary outcomes

Absence from school

Five studies investigated absenteeism, but using different outcome definitions. Some studies assessed absenteeism related to sickness in general or to upper respiratory tract illnesses, whereas others presented results for absenteeism in general without presenting reasons: Ritzel 1966 assessed absenteeism due to cold symptoms (total number of absence days). Reiman 2018 evaluated absenteeism due to sickness and influenza‐like illness (with symptoms: fever + cough or fever + sore throat) and for all reasons (sickness, influenza‐like illness and vacation). Green 1975 investigated total absenteeism and absenteeism due to illness, e.g. due to cold, in 12 public schools. As the data for absenteeism due to cold were only presented for a subsample, total absenteeism during the heating periods between 1960 and 1970 were presented here.

In Sale 1972, four participant groups were established: group I (humidification at school and at home), group II (humidification at school only), group III (humidification at home only) and group IV (no humidification). In order to assign an intervention group, we pooled groups I and II, and groups III and IV were considered as the control group. Retrospectively, paediatricians of the children in groups I to III reviewed their records about the frequency and severity of illnesses. The results for group IV remain unreported, and we therefore present here the average weekly absence due to all causes.

Sataloff 1963 reported the average days of absence and the average number of illnesses of included children. As absences due to respiratory infections were not specifically assessed but only suggested, we refer to the average days of absence (“average number of school days missed”) in this review.

Excluded studies

At the full‐text screening, we excluded 192 studies as outlined in Figure 3, as they did not meet our inclusion criteria for study design (n = 92), intervention (n = 34), setting (n= 3), population targeted (n = 2), or outcome (n = 1). In total, five excluded studies were performed in tropical or subtropical climate zones and 55 were excluded for other reasons (e.g. reviews, book chapters, letters, studies dealing with other topics). The excluded studies with the reasons for exclusion are presented in the Characteristics of excluded studies. We removed the duplicates from the list of excluded studies. For some studies, there were several reasons for exclusion. We therefore decided to prioritise the exclusion criteria according to the sequence in the PICOS‐scheme (participants, intervention, comparator, outcome, study design).

Risk of bias in included studies

See Figure 4 and Figure 5 for an overview of our judgement of the risk of bias by study. Since the figures contain the risk of bias assessments for randomised, non‐randomised and cross‐over studies, cells that were not applicable to a study design remain empty.


Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.


Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

We did not extract the data and did not conduct the risk of bias assessment for the study of Enomoto‐Koshimizu 2002, as it presented results for the intervention and control groups together. As we could not analyse the results of this study, we did not assess its quality.

Allocation

As one study (Reinikainen 1992) was randomised at a group level, the bias criteria: random sequence generation and allocation concealment were assessed for this study only. However, the method of randomisation was not stated, and we therefore assessed it as having an unclear risk of bias. Allocation concealment was not reported and was therefore rated as unclear.

Blinding

We assessed blinding of participants or organisations and, if applicable, outcome assessors. In the case of self‐reported questionnaires, blinding is not applicable for the outcome assessment tool. Due to lack of information on blinding, most of the studies had unclear risk of bias. For one study (Sale 1972), we rated the risk of performance bias as high, because parents of each child were informed in advance about the purpose of the study and the harmful effects of dry heated air with a booklet, and were encouraged to co‐operate.

Incomplete outcome data

We judged the risk of attrition bias to be low in six studies (Gavhed 2005; Green 1981; Hashiguchi 2008; Norbäck 2000; Reiman 2018; Ritzel 1966) and unclear in four studies (Green 1975; Reinikainen 2003; Sale 1972; Sataloff 1963). As the percentage of withdrawals and dropouts exceeded 20% for short‐term follow‐up, Nordström 1994 was classified as having a high risk of bias. In Reinikainen 1992 missing outcome data were observed without presenting the reasons for it.

Selective reporting

Selective reporting was difficult to judge because none of the included studies had published a protocol. As we therefore had insufficient information to permit a judgement of low risk or high risk, we assigned all studies as having an unclear risk of bias. We did not find any indications in the included studies that prespecified outcomes were not reported.

Other potential sources of bias

As other potential sources of bias, we considered seasonality for the conduct of the study and exposure conditions before the start of the study. For five studies (Green 1975Green 1981Reinikainen 2003Ritzel 1966Sale 1972) we had insufficient information to assess this domain, and therefore classified these studies as having some concerns. Five studies appeared to be free of other sources of bias (Gavhed 2005Hashiguchi 2008Norbäck 2000Reiman 2018Reinikainen 1992). Furthermore, these trials were seasonally conducted during the heating period and in the study setting, the participants were exposed to the same indoor air condition before the start of the study. Because of the dynamic population in Nordström 1994, we judged it to be at high risk of bias. As due to technical problems there was virtually no difference between humidity levels in the control and the intervention groups, Sataloff 1963 was classified as having a high risk of bias.

Bias due to confounding

All studies were assessed for confounding. Age, gender, season, comorbidities, atopic conditions and co‐exposures (especially temperature) were considered as relevant confounders. If at least 60% or more of the relevant confounders were considered in the statistical analysis and studies also used either restriction, matching/pre‐stratification, and/or adjustment for confounding in the statistical models, we rated studies at low risk of bias. According to these criteria, Green 1975Green 1981Hashiguchi 2008Reiman 2018Ritzel 1966Sale 1972Sataloff 1963 were classified as high risk of bias. Due to a cross‐over study design where each participant served as its own control, all three cross‐over studies (Gavhed 2005Reinikainen 1992Reinikainen 2003) had low risk of bias. Norbäck 2000 and Nordström 1994 considered at least 60% of the relevant confounders in the statistical analysis and were therefore judged to have a low risk of bias.

Bias due to selection of participants into the study (non‐randomised studies)

In the non‐randomised studies we judged selection of participants due to the inclusion and exclusion criteria as reported in the articles. Most of the included studies had insufficient information to permit judgement of low risk or high risk of bias. Hence, the selection was classified as having some concerns. In Norbäck 2000Nordström 1994Reinikainen 2003Ritzel 1966 there were no indications of bias resulting from inclusion and exclusion criteria.

Bias due to inappropriate use of the cross‐over design and carry‐over effects (cross‐over studies)

All three cross‐over studies (Gavhed 2005Reinikainen 1992Reinikainen 2003) were considered as having a low risk of bias.

Overall risk of bias by study

We judged studies to have a low overall risk of bias if we assessed them to have a low risk of bias in the following domains: confounding, blinding of participants, incomplete outcome data. This left us with no studies at low risk of bias, but all at either unclear (Gavhed 2005Reinikainen 2003) or high risk of bias (Green 1975Green 1981Hashiguchi 2008Norbäck 2000Nordström 1994Reiman 2018Reinikainen 1992Ritzel 1966Sale 1972Sataloff 1963).

Effects of interventions

See: Summary of findings 1 Summary of findings table 'dryness symptoms'; Summary of findings 2 Summary of findings table 'adverse effects' ; Summary of findings 3 Summary of findings 'absenteeism'

See: summary of findings Table 1summary of findings Table 2summary of findings Table 3.

There is one comparison: central or local indoor air humidification versus no humidification. Studies did not measure effects of other interventions. Due to the heterogeneity of follow‐up times and differences in outcomes and outcome definitions, it was impossible to draw conclusions about the effects of humidification versus no humidification for different follow‐up times. We are therefore uncertain about the effects, if any, of humidification on outcomes after a month, a season or several seasons.

Primary outcomes

Outcome 'dry eye'

summary of findings Table 1 outlines details about the effectiveness of humidification on dryness symptoms of the eye. This outcome was assessed in five studies (data analysed of 720 participants): three cross‐over studies (one RCT: (Reinikainen 1992) and two non‐RCTs: (Reinikainen 2003Gavhed 2005)) and two before‐after studies (Nordström 1994Norbäck 2000).

The cluster randomised cross‐over study Reinikainen 1992, conducted over six weeks, showed a significant reduction in eye dryness following indoor air humidification. The study reported a risk ratio for dry eye symptoms of 0.64 (95% CI 0.44 to 0.93), which indicated that people were 36% less likely to experience dryness symptoms during the humidified phase compared to the non‐humidified phase. After the transformation of the results according to Elbourne 2002, the calculated OR was 0.54 (95% CI 0.37 to 0.79) (low‐certainty evidence) (Analysis 1.1).

We combined the results of two cluster non‐randomised cross‐over trials (Reinikainen 2003Gavhed 2005) and revealed non‐significant positive effects on eye dryness following indoor air humidification over a study duration of six and eight weeks, respectively (OR 0.58, 95% CI 0.27 to 1.25) (low‐certainty evidence) (Analysis 1.2). SImilarly, two before‐after studies (Norbäck 2000Nordström 1994) showed a non‐significant positive effect of indoor air humidification on dry‐eye symptoms over a study period of six weeks and four months, respectively (OR 0.57, 95% CI 0.23 to 1.41) (very low‐certainty evidence) (Analysis 1.3).

In the before‐after study of Norbäck 2000, the tear breakup times were similar in both the intervention and control groups (Analysis 1.5).

Outcome 'dry skin'

This outcome was investigated in four trials (two cluster non‐RCT cross‐over and two before‐after studies) (data of 528 participants entered analysis). Gavhed 2005 (cluster non‐RCT cross‐over study) showed a significant effect of humidification on dryness of the skin: OR 0.43 (95% CI 0.19 to 0.96). In Reinikainen 2003, humidification decreased skin dryness, but the result was not statistical significant: OR 0.89 (95% CI 0.52 to 1.51). Both these cross‐over studies showed a non‐significant alleviation of skin dryness following indoor air humidification over a study period of one to three months: OR 0.66 (95% CI 0.33 to 1.32) (low‐certainty evidence) (Analysis 1.6). One before‐after study yielded a positive effect of indoor air humidification on skin dryness over a study period of 12 weeks (Hashiguchi 2008), whereas the other before‐after study showed no effect following indoor air humidification over a study period of four months. The pooled analysis of these two trials provided no statistically significant result (OR 0.69, 95% CI 0.33 to 1.47) (Analysis 1.9).

Outcome 'skin symptoms'

Office workers in Reinikainen 1992 reported fewer skin symptoms of dryness, irritation or itching during the humidification phase than under non‐humidified conditions: OR 0.59 (95% CI 0.39 to 0.89) (Analysis 1.7). This difference in dermal symptoms reached statistical significance.

Skin results for Norbäck 2000 are not included here, as the symptoms were not unequivocally considered as dryness symptoms (“facial itching, facial rash, itching on the hands, rash on the hands, or eczema”).

Outcome 'dry nose'

The results are summarised in summary of findings Table 1. This outcome was reported in two cross‐over studies (data analysed of 579 participants): one RCT: Reinikainen 1992 and one non‐RCT: Reinikainen 2003. The cluster non‐randomised cross‐over study (Reinikainen 2003) reported an alleviation of nose dryness following indoor air humidification over a study period of six weeks. Hence, the result did not reach statistical significance: OR 0.87 (95% CI 0.53 to 1.42), and was of low‐certainty evidence (Analysis 1.11). The cluster‐randomised cross‐over study (Reinikainen 1992) revealed no effect of indoor air humidification on nose dryness over a study period of six weeks: OR 1.08 (95% CI 0.73 to 1.60) (low‐certainty evidence) (Analysis 1.12).

Outcome 'nose symptoms'

The outcome 'nose symptoms' in Norbäck 2000 comprised runny nose, nasal itching, sneezing or nasal obstruction. No effect of air humidification on nose symptoms was found (Analysis 1.13). Furthermore, no significant effects of humidification on any of the measured physiological signs during the study period of six weeks in exposed participants and controls were observed (Analysis 1.14).

Outcome 'airway symptoms'

Nordström 1994 investigated airway symptoms such as 'irritated, stuffy or running nose, hoarse or dry throat, or cough'. No significant differences between intervention and control participants were found (Analysis 1.15).

Outcome 'dry mouth and throat'

The five categories of the symptoms' frequency were pooled to two categories, as described earlier (Gavhed 2005). The air humidification had a positive effect on 'dry mouth and throat': OR 0.25 (95% CI 0.11 to 0.57) (Analysis 1.16). More specifically, under humidified conditions dry‐mouth‐and‐throat‐symptoms were less frequently reported than under non‐humidified conditions.

Outcome 'pharyngeal dryness'

Humidification increased pharyngeal dryness: OR 1.15 (95% CI 0.63 to 2.11) in Reinikainen 2003 (Analysis 1.17). In Reinikainen 1992 the intervention led to an alleviation of pharyngeal irritation: OR 0.73 (95% CI 0.49 to 1.07) (Analysis 1.18). Neither result was statistically significant.

Secondary outcomes

Outcome 'perception of dryness'

Perception of dryness was assessed in five studies: one cluster non‐RCT cross‐over study (Gavhed 2005), one cluster RCT cross‐over study (Reinikainen 1992) and three before‐after studies (Hashiguchi 2008Norbäck 2000Nordström 1994).

Norbäck 2000 showed that air dryness was reduced after the six‐week period of humidification (Analysis 1.21) and Nordström 1994 presented the same effect after four months (Analysis 1.23 and Analysis 1.24). Following pooling of the data, the pooled standardised mean difference was −0.48 (CI 95% −3.49 to 2.54) (Analysis 1.25). The heterogeneity between the studies was considerable (I2 value of 97%).

Hashiguchi 2008 found a statistically significant reduction in the perception of dryness following air humidification (Analysis 1.22). We pooled the two before‐after studies of Norbäck 2000 and Hashiguchi 2008, and the result showed a statistically significant effect of air humidification on the perception of dryness: OR 0.05, CI 95% 0.01 to 0.22 (Analysis 1.26). The heterogeneity between the studies was considerable (I2 value of 99%).

The only cluster‐randomised cross‐over study (Reinikainen 1992) reported that the sensation of dryness was significantly increased during the non‐humidified phase compare with during humidification (Analysis 1.19). Similarly, Gavhed 2005 revealed a significant effect of humidification on the perception of dryness (Analysis 1.20).

Outcome 'absenteeism'

Green 1981 had investigated absenteeism in three hospitals during three winter seasons (October to April) in the years 1973 to 1974, 1974 to 1975, 1975 to 1976, and concluded that increasing the relative humidity had reduced absenteeism (pooled mean difference over three seasons −0.57 (CI 95% −0.61 to −0.53) (Analysis 1.33).

Five studies in the educational setting investigated effects of air humidification on absenteeism; see summary of findings Table 3.

Ritzel 1966 showed a reduction in absenteeism due to cold symptoms in the humidified versus non‐humidified kindergartens: OR 0.54, CI 95% 0.45 to 0.65 (Analysis 2.1). Sataloff 1963 revealed no reduction in the average days of absence under humidified conditions in a public school when compared to the non‐humidified condition (Analysis 2.2). According to Sale 1972, the average weekly absence due to all causes was reduced in the humidified schools versus the non‐humidified ones: OR 0.38, Cl 95% 0.15 to 0.96 (Analysis 2.3).

The average 10‐year absenteeism rate in the non‐humidified schools was found to be 5.08%, and 4.63% in the humidified schools, which was reported to be statistically significant at a 95% confidence level (Green 1975) (Analysis 2.4).

The number of absences due to illness was the same in the humidified and the control rooms (Reiman 2018) (Analysis 2.5). The percentage of students with influenza‐like illness absences was lower under the humidified versus the non‐humidified condition (no statistical testing) (Analysis 2.6). These results were supported by the distribution of the positive influenza virus samples investigated by PCR under both conditions: in the humidified rooms, the genome copies per cubic meter of the influenza A virus were lower than in the non‐humidified rooms.

Adverse events

Four studies investigated 'perception of stuffiness', which was considered to be an adverse effect of humidification (one cluster‐RCT cross‐over trial, one cluster non‐RCT cross‐over trial and two before‐after studies) (summary of findings Table 2). Both cross‐over studies (Reinikainen 1992Reinikainen 2003) showed that the perception of stuffiness was more common during humidification than in the non‐humidified phase after six weeks (Analysis 1.27Analysis 1.28) which was found to be statistically significant: OR 2.18, CI 95% 1.47 to 3.23 and OR 1.70, CI 95% 1.10 to 2.61. In both before‐after studies (Norbäck 2000Nordström 1994) no statistically significant effects of air humidification were observed for the perception of stuffy air after one and four months (pooled standardised mean difference 0.24 (−0.30 to 0.78)) (Analysis 1.29Analysis 1.30Analysis 1.31Analysis 1.32).

Discussion

Summary of main results

This systematic review aimed to assess the effectiveness of interventions in reducing or preventing dryness symptoms and upper respiratory infections following humidification of indoor air. Given the heterogeneity across study methods, types of interventions, outcome definitions, and outcome assessments, it was difficult to comprehensively interpret the studies. We did not perform sensitivity analysis because there was not a sufficient number of studies that could be combined. The outcome 'upper respiratory tract infections' was not investigated in the included studies.

The data from 12 studies were included, which were all conducted in high‐income countries and were performed over a time span of more than 50 years. The effects of indoor air humidification were targeted to address adults and children and were therefore assessed in two settings, occupational and educational. Available studies covered workplaces such as offices and hospitals in the occupational setting, and kindergarten and schools in the educational setting.

This systematic review shows inconsistent findings, with low to very low‐certainty evidence that indoor air humidification compared to no indoor air humidification in the workplace decreases dryness symptoms of the eye (summary of findings Table 1), of the skin (summary of findings Table 1) and of the upper respiratory tract (summary of findings Table 1).

Furthermore, there is very low‐certainty evidence about the causal relationship between increasing indoor air humidity and reduction in absenteeism (summary of findings Table 3). Improvements in dryness symptoms and perception were not consistent between studies, and ranged from no effects to clearly positive effects. Perception of dryness, such as dry air, was assessed in five studies and was the only (secondary) outcome that was consistently reduced following air humidification across all studies.

Overall completeness and applicability of evidence

There are a wide range of factors contributing to indoor air quality and in turn, affecting the well‐being and health of occupants. The indoor conditions vary considerably and are related to the complex interplay of exposure to ventilation characteristics, chemicals and microbial contamination. Further, the indoor air climate resulting from a combination of temperature, radiation temperature, air velocity and humidity differs between workplaces, as well as between schools. The conditions at one particular location might change continuously within a day, days, weeks and seasons. As well as these external factors, there are various individual factors contributing to the physiological response to the particular environmental conditions (Wolkoff 2018aWolkoff 2018b). This complexity poses a challenge for the evaluation of the effect of a single indoor factor, air humidification, on dryness symptoms and perception under field conditions. Hence, the appropriate method used for the assessment is of major significance.

The 12 studies described in this review covered the effectiveness of the single intervention we aimed to address, i.e. whether indoor air humidification reduces or prevents dryness symptoms of the eyes, the skin and the upper respiratory tract or URT infections, and included both settings, the occupational and the educational.

All studies were performed in high‐income countries. On the one hand, this is not surprising, as we excluded subtropical and tropical climatic regions. On the other, this selection of studies from few countries might not paint the whole picture, as other geographic and cultural regions might contribute further perspectives.

Occupational setting

We presented data from seven studies. The analysed studies are related to two different working populations: office workers and hospital staff, who were exposed to humidifiers at their workplaces. Only one study (Green 1975) assessed the secondary outcome of absenteeism.

Most of the studies included (daytime) employees at the target workplace, without any restriction by age, gender or other factors. However, due to limited information about the personal characteristics (age, gender and other factors), a few studies with a limited number of participants and only two types of workplaces, the results have limited applicability to the general working population.

Although office workers and hospital staff present a major part of the indoor work force, we did not find studies including other types of workplaces, and might add more and different results if they existed. The various types of factory workers, workers in the food industry or in sales present different occupational sectors with their own environmental conditions. It is notable that one study targeting factory workers could not be extracted due to the method of data reporting.

All studies compared humidification using humidifiers to no use of humidifiers. No studies of other measures to potentially increase air humidity, such as putting plants around work places, met our inclusion criteria. Apart from the humidification technologies, more basic humidification measures might also be difficult to standardise and maintain.

The primary outcomes were at least partially targeted by the included studies, but sick leave, absenteeism and perceived air quality were the only secondary outcomes assessed. Task performance and productivity associated with indoor air humidity, as well as the costs of the intervention to increase indoor air humidity, might be important factors to be investigated. These might be key considerations to inform policy and practice and to evaluate and implement (new) measures.

Educational settings

In the educational setting we included five studies, which investigated young children aged between two and six years, and (mainly) primary school children. All of these studies considered only the secondary outcome 'absenteeism', including limited data on sick leave attributed to upper respiratory tract infections. As various outcome definitions were used, all studies were interpreted separately. Hence, conclusions about the applicability to the general child population cannot be made.

In one study, school children of grades 1 to 8 were considered, whereas all other studies included children up to grade 3 at maximum. No studies were therefore eligible which included older teenagers or young adults. This meant that we could not identify interventions targeting secondary or tertiary (higher) education.

Quality of the evidence

Overall, there was very low‐ to low‐certainty evidence that humidification prevented or reduced dryness symptoms of the eyes, upper respiratory tract and skin. Furthermore, we judged the certainty of evidence as very low for absenteeism. We made this judgement due to a high risk of bias. Most of the included studies had substantial methodological shortcomings based on the Cochrane risk of bias tool that we used for the risk of bias assessment (Higgins 2011).

It is very challenging to study the effects of humidification on dryness symptoms, upper respiratory infections and absenteeism. On the one hand, there are many different environmental factors in the indoor air, with personal factors influencing the condition of the skin and mucosa. On the other hand, the symptoms caused by these factors are similar, and it is therefore difficult to link them causally. Hence, the use of appropriate study designs and adjustment for confounding factors are essential in order to assess the effectiveness of humidification on dryness symptoms. Only three studies had a controlled cross‐over study design, where participants serve as their own control, reducing the influence of confounding covariates. Among these three trials, only one used randomisation, contributing to additionally controlling for confounding. Mostly, controlled before‐after and non‐randomised parallel‐group controlled studies did not consider relevant confounders or did not adjust for them.

Except for four studies (two in each setting), most studies reported blinding of participants. Blinding of outcome assessors was not described.

Most studies evaluated a wide range of different symptoms, using different outcome definitions. Various self‐administered questionnaires with different scoring systems were used to assess the effect of humidification. In two studies (Norbäck 2000Nordström 1994), a modified version of a validated questionnaire for recording symptoms of the 'sick building syndrome' were used. As this questionnaire was exploratory and without test statistics, we could not consider it as a reference tool for assessing work‐related dryness symptoms. The other studies did not use standardised questionnaires, so the outcome assessment in the included studies for primary outcomes was of unknown reliability, validity, and sensitivity, and was not objectively assessed. In only one study were the effects investigated by objective measurements of physiological signs.

Various outcome definitions were used for the secondary outcome 'absenteeism'. It was self‐reported or reported by parents, and some studies assessed absenteeism attributed to sickness in general or to upper respiratory illnesses. Furthermore, studies presented results for absenteeism in general, without stating the reasons.

Most studies suffered from small sample sizes, which put them at risk of imprecision and lack of power, which could lead to under‐ or overestimation of intervention effects.

In order to evaluate the sustainability of the humidification impacts on dryness symptoms, we intended to distinguish three time scales for the study duration: up to one month, between one month and three months (one season) and longer than three months. As the number of studies was small and very heterogeneous, we dropped these subgroup analyses and could not evaluate the impact of exposure time on the symptoms.

This review addressed one type of intervention, which aimed to increase the indoor air humidity level. Central and local humidification using different devices were described in order to humidify the indoor air. Due to the limited number of studies and their considerable heterogeneity, we could not explore the effect of using different types of humidifiers on symptoms and absenteeism.

Potential biases in the review process

We performed searches in general medicine, health and interdisciplinary databases as well as in occupational ones, and consulted websites of appropriate societies and reference lists of included studies. We did not search for specific upper respiratory infectious disease entities, such as, for example, adenovirus or rhinovirus infections or influenza. We assumed we had covered specific infections by searching for upper respiratory symptoms in titles and abstracts. Furthermore, we combined the variables targeting humidity with the variables describing the indoor setting in the title and abstract screening. This prevented us from detecting an article combining e.g. influenza and humidity and not referring to the indoor setting. We found one such article by searching for influenza for other reasons (Reiman 2018).

One cross‐over study (Gavhed 2005) was analysed and reported as a parallel‐group design. Based on the data provided by the author, we calculated first the outcome results for the first phase of the cross‐over study considering it as a parallel‐group step (questionnaire two). We then considered all possible paired tables comparing the outcomes of the questionnaires two and three. We calculated odds ratios based on McNemar's test. We then chose the option as close as possible to the first phase result as our outcome result and entered it into Revman.

Based on the studies identified, we could not perform sensitivity analyses or assess a publication bias using funnel plots.

Agreements and disagreements with other studies or reviews

A variety of reviews have assessed the effect of indoor air humidity on human health (Arundel 1986Green 1979Guggenbichler 2007Mendell 1993Nagda 2001Pfluger 2013; ; Von Hahn 2007Wolkoff 2007Wolkoff 2008Wolkoff 2018aWolkoff 2018b). To the best of our knowledge, there were no other published systematic reviews on the effect of indoor air humidification on dryness symptoms and absenteeism. The previous published reviews were not conducted according to the requirements of a systematic review. Previous reviews included studies with different study designs and settings (e.g. chamber studies) (Arundel 1986Mendell 1993Nagda 2001Pfluger 2013Von Hahn 2007), and diverse populations including cabin crew personnel (Lindgren 2005), army recruits (Gelperin 1973), and factory workers (Milton 2000). The quality of the included studies was not assessed in most of these reviews, so that the evidence level was not stated. It is also important to note that most of them did not define a specific research question, but rather narratively summarised the literature on different effects of indoor air on health (Pfluger 2013Von Hahn 2007Wolkoff 2006Wolkoff 2008Wolkoff 2018b). For these reasons, a direct comparison between the findings of our review and the other reviews was not possible.

It is noteworthy that most of the reviews found positive effects of air humidification (Arundel 1986Green 1979Guggenbichler 2007Nagda 2001Pfluger 2013Wolkoff 2006Wolkoff 2008Wolkoff 2018aWolkoff 2018b). Arundel 1986 suggested that relative humidity (RH) could influence the incidence of respiratory infections. The incidence of absenteeism or respiratory infections was found to be lower among people working or living in environments with mid‐range RH (50% to 70%) as opposed to low or high RH. Green 1979 concluded that an increase in indoor relative humidity by humidification in winter significantly decreased the occurrence or absenteeism, or both, due to colds. It was recommended that winter indoor humidity should be kept as high as possible without causing building damage by condensation, but should not exceed 50% RH. Pfluger 2013 analysed the physiological effects of low indoor air humidity on mucous membranes, skin and perception of air humidity. The authors concluded that there is a need for a lower limit in the range of long‐term indoor air humidity. Wolkoff 2006 and Wolkoff 2008 stated that the humidity level plays an important role in the development of eye irritation symptoms, which is related to its influence on the exposure factors in indoor environments. However, it is not clear whether low relative humidity is a direct cause of eye symptomatology. Dry‐air conditions exacerbate the development of eye irritation symptoms, which can be explained by changes in physiological signs. An Increase in humidity level contributes to the decreasing perception of dry air and eye.

In contrast, Mendell 1993 showed inconsistent effects of increasing in air humidification on dryness symptoms, which is in agreement with our review. This review summarised the literature about the relationship between work‐related non‐specific symptoms and the variety of workplace environmental factors, and also discussed methodological issues important for the interpretation of epidemiologic studies. A total of 32 studies with different study design were included, whereas studies performed in laboratories were excluded. The included studies were categorised as experimental or observational. Of these, 12 trials investigated the influence of low humidity on work‐related symptoms. In this review, the internal study validity was evaluated and interpreted. Mendell 1993 concluded that short‐term humidification reduced symptoms by eliminating the negative health effects of excessively low humidity and that long‐term humidification might reduce some symptoms, but more substantially, might increase the risk of symptoms from microbiologic contamination. More long‐term studies were suggested for future research.

Von Hahn 2007 summarises various aspects of the effects of relative humidity on human health. This narrative review includes 29 studies with different study designs and assesses different outcomes, including smell perception, perception of comfort, incidence of colds, occurrence of 'sick building syndrome', symptoms of eye, upper respiratory tract and skin. The quality of the studies was not assessed. The studies included in this review showed contradictory findings. The assertion that a relative humidity of at least 30% is beneficial for a number of self‐reported symptoms, incidence of colds and occurrence of 'sick building syndrome' could not be supported by the data. 

The impacts of indoor plants on air quality and microclimate are highlighted in the systematic review by Han 2020, which summarised information from 88 studies. Primary effects like air purification were followed by secondary effects like increased humidity and reduced room temperature. In turn, the indoor environment was perceived as more comfortable. However, most of the results were mainly obtained in laboratory settings. Some studies were field experiments (18 studies), conducted at work places (hospitals, offices) and in classrooms. The exposure duration was between four hours and nine months. The effects of indoor plants on dryness symptoms were not investigated in the included studies.

Association of indoor relative humidity and exposure factors related to adverse health effects (Alsmo 2014)

Figuras y tablas -
Figure 1

Association of indoor relative humidity and exposure factors related to adverse health effects (Alsmo 2014)

Description of this Cochrane review. URT = upper respiratory tract.

Figuras y tablas -
Figure 2

Description of this Cochrane review. URT = upper respiratory tract.

Study flow diagram.

Figuras y tablas -
Figure 3

Study flow diagram.

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

Figuras y tablas -
Figure 4

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

Figuras y tablas -
Figure 5

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 1: Dry eye: Cross‐over study cluster RCT

Figuras y tablas -
Analysis 1.1

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 1: Dry eye: Cross‐over study cluster RCT

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 2: Dry Eye: Cross‐over Studies cluster non‐RCT

Figuras y tablas -
Analysis 1.2

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 2: Dry Eye: Cross‐over Studies cluster non‐RCT

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 3: Dry Eye: Before‐and‐after studies

Figuras y tablas -
Analysis 1.3

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 3: Dry Eye: Before‐and‐after studies

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 4: Dry Eye: Before‐and‐after studies

Figuras y tablas -
Analysis 1.4

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 4: Dry Eye: Before‐and‐after studies

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 5: Eye: Change in breakup time of tears (s)

Figuras y tablas -
Analysis 1.5

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 5: Eye: Change in breakup time of tears (s)

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 6: Dry Skin: Crossover studies cluster non‐RCT

Figuras y tablas -
Analysis 1.6

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 6: Dry Skin: Crossover studies cluster non‐RCT

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 7: Skin Symptoms: Cross‐over study cluster RCT

Figuras y tablas -
Analysis 1.7

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 7: Skin Symptoms: Cross‐over study cluster RCT

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 8: Dry Skin: Before‐and‐after studies

Figuras y tablas -
Analysis 1.8

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 8: Dry Skin: Before‐and‐after studies

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 9: Dry skin: Before‐and‐after studies

Figuras y tablas -
Analysis 1.9

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 9: Dry skin: Before‐and‐after studies

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 10: Skin Symptoms: Before‐and‐after studies

Figuras y tablas -
Analysis 1.10

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 10: Skin Symptoms: Before‐and‐after studies

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 11: Dry Nose: Cross‐over study cluster non‐RCT

Figuras y tablas -
Analysis 1.11

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 11: Dry Nose: Cross‐over study cluster non‐RCT

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 12: Dry Nose: Cross‐over study cluster RCT

Figuras y tablas -
Analysis 1.12

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 12: Dry Nose: Cross‐over study cluster RCT

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 13: Nose Symptoms: Before‐and‐after studies

Figuras y tablas -
Analysis 1.13

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 13: Nose Symptoms: Before‐and‐after studies

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 14: Change of nasal signs

Figuras y tablas -
Analysis 1.14

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 14: Change of nasal signs

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 15: Airway Symptoms: Before‐and‐after studies

Figuras y tablas -
Analysis 1.15

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 15: Airway Symptoms: Before‐and‐after studies

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 16: Dry mouth and throat: Cross‐over study cluster non‐RCT

Figuras y tablas -
Analysis 1.16

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 16: Dry mouth and throat: Cross‐over study cluster non‐RCT

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 17: Pharyngeal Dryness: Cross‐over study cluster non‐RCT

Figuras y tablas -
Analysis 1.17

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 17: Pharyngeal Dryness: Cross‐over study cluster non‐RCT

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 18: Pharyngeal Dryness: Cross‐over study cluster RCT

Figuras y tablas -
Analysis 1.18

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 18: Pharyngeal Dryness: Cross‐over study cluster RCT

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 19: Perception of dryness: Cross‐over study cluster RCT

Figuras y tablas -
Analysis 1.19

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 19: Perception of dryness: Cross‐over study cluster RCT

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 20: Perception of dryness: Cross‐over study cluster non‐RCT

Figuras y tablas -
Analysis 1.20

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 20: Perception of dryness: Cross‐over study cluster non‐RCT

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 21: Perception of dryness: Before‐and‐after study

Figuras y tablas -
Analysis 1.21

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 21: Perception of dryness: Before‐and‐after study

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 22: Perception of dryness: Before‐and‐after study

Figuras y tablas -
Analysis 1.22

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 22: Perception of dryness: Before‐and‐after study

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 23: Increased perception of dryness: Before‐and‐after study

Figuras y tablas -
Analysis 1.23

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 23: Increased perception of dryness: Before‐and‐after study

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 24: Decreased perception of dryness: Before‐and‐after study

Figuras y tablas -
Analysis 1.24

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 24: Decreased perception of dryness: Before‐and‐after study

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 25: Perception of dryness: Before‐and‐after studies

Figuras y tablas -
Analysis 1.25

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 25: Perception of dryness: Before‐and‐after studies

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 26: Perception of dryness: Before‐and‐after studies

Figuras y tablas -
Analysis 1.26

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 26: Perception of dryness: Before‐and‐after studies

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 27: Perception of stuffiness: Cross‐over study cluster RCT

Figuras y tablas -
Analysis 1.27

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 27: Perception of stuffiness: Cross‐over study cluster RCT

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 28: Perception of stuffiness: Cross‐over study cluster non‐RCT

Figuras y tablas -
Analysis 1.28

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 28: Perception of stuffiness: Cross‐over study cluster non‐RCT

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 29: Perception of stuffiness: Before‐and‐after studies

Figuras y tablas -
Analysis 1.29

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 29: Perception of stuffiness: Before‐and‐after studies

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 30: Perception of stuffiness: Before‐and‐after studies

Figuras y tablas -
Analysis 1.30

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 30: Perception of stuffiness: Before‐and‐after studies

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 31: Increased perception of stuffiness: Before‐and‐after studies

Figuras y tablas -
Analysis 1.31

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 31: Increased perception of stuffiness: Before‐and‐after studies

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 32: Decreased perception of stuffiness: Before‐and‐after studies

Figuras y tablas -
Analysis 1.32

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 32: Decreased perception of stuffiness: Before‐and‐after studies

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 33: Absenteeism: Controlled Study non‐RCT

Figuras y tablas -
Analysis 1.33

Comparison 1: Humidification vs no humidification in occupational setting, Outcome 33: Absenteeism: Controlled Study non‐RCT

Comparison 2: Humidification vs no humidification in educational setting, Outcome 1: Absenteeism due to cold symptoms: Controlled Study non‐RCT

Figuras y tablas -
Analysis 2.1

Comparison 2: Humidification vs no humidification in educational setting, Outcome 1: Absenteeism due to cold symptoms: Controlled Study non‐RCT

Average days of absence per child: Controlled Study non‐RCT

Study

Intervention

Grade 1

Grade 2

Grade 3

Sataloff 1963

No Humidification

7.4

8.6

6.1

Humidification

9.8

10.4

7.2

Figuras y tablas -
Analysis 2.2

Comparison 2: Humidification vs no humidification in educational setting, Outcome 2: Average days of absence per child: Controlled Study non‐RCT

Comparison 2: Humidification vs no humidification in educational setting, Outcome 3: Average weekly absense: Controlled Study non‐RCT

Figuras y tablas -
Analysis 2.3

Comparison 2: Humidification vs no humidification in educational setting, Outcome 3: Average weekly absense: Controlled Study non‐RCT

Average total absenteeism: Controlled Study (1960‐1971) non‐RCT

Study

Humidification

No Humidification

Green 1975

4.63%

5.08%

Figuras y tablas -
Analysis 2.4

Comparison 2: Humidification vs no humidification in educational setting, Outcome 4: Average total absenteeism: Controlled Study (1960‐1971) non‐RCT

Absenteeism due to sickness: Controlled Study non‐RCT

Study

Non‐humidification ‐ % out

Non ‐ humidification ‐ Total attendance

Humidification % out

Humidification ‐ Total attendance

Reiman 2018

1.29

1788

1.00

2293

Figuras y tablas -
Analysis 2.5

Comparison 2: Humidification vs no humidification in educational setting, Outcome 5: Absenteeism due to sickness: Controlled Study non‐RCT

Absenteeism due to influenza like illness: Controlled Study non‐RCT

Study

Non humidification ‐ % out

Non humidification ‐ Total attendance

Humidification ‐ % out

Humdification ‐ Total attendance

Reiman 2018

0.39

1788

0.13

2293

Figuras y tablas -
Analysis 2.6

Comparison 2: Humidification vs no humidification in educational setting, Outcome 6: Absenteeism due to influenza like illness: Controlled Study non‐RCT

Summary of findings 1. Summary of findings table 'dryness symptoms'

Indoor air humidification compared with no indoor air humidification for prevention or reducing dryness symptoms of the eyes, skin and nose (URT)

Population: Adults
Setting: Occupational
Intervention: Indoor air humidification
Comparison: No indoor air humidification

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of participants
(studies)#

Quality of the evidence
(GRADE)

Comments

Risk with no humidification

Risk with humidification

Dry eye

Cross‐over study (cluster‐RCT) after 6 weeks

Study population

OR 0.54
(0.37 to 0.79)

211
(1 cross‐over cluster‐RCT)

⊕⊕⊝⊝
LOWa

The cluster‐randomised cross‐over study reported a significant reduction in eye dryness following indoor air humidification over a study period of 6 weeks

359 per 1000

232 per 1000
(172 to 307)

Dry eye

Cross‐over studies (cluster non‐RCT) after 6 – 12 weeks

Study population

OR 0.58
(0.27 to 1.25)

407
(2 cross‐over cluster non‐RCTs)

⊕⊕⊝⊝
LOW

2 cluster non‐randomised cross‐over studies reported non‐significant positive effects on eye dryness following indoor air humidification over a study period of 1 ‐ 3 months

359 per 1000

245 per 1000
(131 to 412)

Dry eye

Before‐and‐after studies after 6 weeks ‐ 4 months

Study population

OR 0.57
(0.23 to 1.41)

102
(2 before‐and‐after studies)

⊕⊝⊝⊝
VERY LOWb, c

2 before‐and‐after studies showed non‐significant positive effect of indoor air humidification on dry eye symptoms over a study period of 6 weeks to 4 months

359 per 1000

242 per 1000
(114 to 441)

 

Dry skin

Cross‐over studies (cluster non‐RCT) after 6 ‐ 12 weeks

Study population

OR 0.66
(0.33 to 1.32)

407
(2 non‐RCT)

⊕⊕⊝⊝
LOW

Both cluster non‐randomised cross‐over studies showed an alleviation of skin dryness following indoor air humidification over a study period of 1 ‐ 3 months

380 per 1'000

288 per 1000
(168 to 447)

Dry skin

Before‐and‐after Studies after 12 weeks to 4 months

Study population

OR 0.69
(0.33 to 1.47)

121
(2 before‐and‐after studies)

⊕⊝⊝⊝
VERY LOWd

1 before‐and‐after study yielded a positive effect of indoor air humidification on skin dryness over a study period of 12 weeks.

1 before‐and‐after study showed no effect following indoor air humidification over a study period of 4 months

380 per 1000

297 per 1000
(168 to 474)

 

Dry nose (dry upper respiratory tract)

Cross‐over study (cluster non‐RCT) after 6 weeks

Study population

OR 0.87
(0.53 to 1.42)

368

(1 non‐RCT)

⊕⊕⊝⊝
LOW

The cluster non‐randomised cross‐over study reported an alleviation of nose dryness following indoor air humidification over a study period of 6 weeks. Hence, the result was not statistically significant

246 per 1000

221 per 1000
(147 to 317)

Dry nose (dry upper respiratory tract)

Cross‐over study (cluster‐RCT) after 6 weeks

Study population

OR 1.08
(0.73 to 1.60)

211
(1 RCT)

⊕⊕⊝⊝
LOWd

The cluster‐randomised cross‐over study revealed no effect of indoor air humidification on nose dryness over a study period of 6 weeks

246 per 1000

259 per 1000
(194 to 337)

 

No studies were identified for URT (Upper respiratory infections)

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
#Number of participants included in the analysis were reported, See Characteristics of included studies for number of recruited and included participants.
CI: Confidence interval; OR: Odds ratio; RCT: randomised controlled trial

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

aDowngraded twice due to high risk of bias: there were missing outcome data (the reason was not stated); the items: randomisation, allocation concealment, blinding unclear, selective outcome reporting were unclear.
bDowngraded twice due to high risk of bias: in one study the percentage of withdrawals and dropouts exceeds 20% for short‐term follow‐up and the results are presented for a dynamic population.
cDowngraded once due to imprecision: small sample sizes.
dDowngraded once due to high risk of bias: lack of control for confounding and other source of bias (dynamic population).

We did not upgrade any of the individual studies.

Figuras y tablas -
Summary of findings 1. Summary of findings table 'dryness symptoms'
Summary of findings 2. Summary of findings table 'adverse effects' 

Humidification compared to no humidification for preventing or reducing of perception of stuffiness

Population: Adults
Setting: Occupational
Intervention: Indoor air humidification
Comparison: No indoor air humidification

Outcomes

Anticipated absolute effects* (95% CI)

Relative effect
(95% CI)

№ of participants
(studies)#

Certainty of the evidence
(GRADE)

Comments

Risk with no humidification

Risk with humidification

Perception of stuffiness: Cross‐over study (cluster‐RCT) after 6 weeks

246 per 1000

416 per 1000
(324 to 513)

OR 2.18
(1.47 to 3.23)

211
(1 cross‐over cluster‐RCT)

⊕⊕⊝⊝
LOWa

The clustered randomised cross‐over study reported more frequent perception of stuffiness over a study period of 6 weeks

Perception of stuffiness: Cross‐over study (cluster non‐RCT) after 6 weeks

246 per 1000

357 per 1000
(264 to 460)

OR 1.70
(1.10 to 2.61)

368

(1 non‐RCT)

⊕⊕⊝⊝
LOW

The cluster‐non‐randomised cross‐over study reported more frequent perception of stuffiness over a study period of 6 weeks

Perception of stuffiness: 2 Before‐and‐after studies after 1‐4 months

246 per 1000

148 per 1000

(‐74 to 192)

St. Mean Diff.

0.24
(−0.30 to 0.78)

102
(2 before‐and‐after studies)

⊕⊝⊝⊝
VERY LOWb, c

2 before‐and‐after studies showed a non‐significant positive effect of indoor air humidification for the perception of stuffy air over a study period of 6 weeks to 4 months

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
# Number of participants included in the analysis were reported, See Characteristics of included studies for number of recruited and included participants.
CI: Confidence interval; OR: Odds ratio; RCT: randomised controlled trial

GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

aDowngraded twice due to high risk of bias: there were missing outcome data (the reason was not stated); the items: randomisation, allocation concealment, blinding unclear, selective outcome reporting were unclear.
bDowngraded twice due to high risk of bias: in one study the percentage of withdrawals and dropouts exceeds 20% for short‐term follow‐up and the results are presented for a dynamic population.
cDowngraded once due to imprecision: small sample sizes.

Figuras y tablas -
Summary of findings 2. Summary of findings table 'adverse effects' 
Summary of findings 3. Summary of findings 'absenteeism'

Indoor air humidification compared with no indoor air humidification for prevention or reducing absenteeism

Patient or population: Children

Settings: Educational

Intervention: Indoor air humidification

Comparison: No indoor air humidification

Outcomes

Illustrative comparative risks* (95% CI)

Relative effect
(95% CI)

No of Participants
(studies)#

Quality of the evidence
(GRADE)

Assumed risk

Corresponding risk

No indoor air humidification

Indoor air humidification

In total 6 non‐randomised, parallel‐group controlled studies were included, 5 in educational and one in an occupational setting. Different outcomes were assessed.

Absenteeism due to cold symptoms

1 study showed a statistically significant reduction in absenteeism due to cold symptoms following indoor air humidification

OR 0.54 (0.45 to 0.65)

232

1 study

⊕⊝⊝⊝
VERY LOWa

Average days of absence per child

No reduction in respiratory illness could be demonstrated following indoor air humidification in 1 study.

 

162

1 study

⊕⊝⊝⊝
VERY LOWa, b

Average weekly absence

1 study revealed a statistically significant decrease in average weekly absence following indoor air humidification.

OR 0.38 (0.15 to 0.96)

263

1 study

⊕⊝⊝⊝
VERY LOWa, c

Average total absenteeism

10‐year‐average of total absenteeism: under humidified condition 4.63% and under non‐humidified condition 5.08%, statistical significance at 95% CI level reported, data not shown

 

N unknown

(12 schools, grades 1 ‐ 8)

⊕⊝⊝⊝
VERY LOWa

Absenteeism due to sickness

In the humidified group the absenteeism due to sickness was the same as in the control group.

 

116

1 study

⊕⊝⊝⊝
VERY LOWa

Absenteeism due to influenza‐like illness

The percentage of students with influenza‐like illness absences was lower under the humidified vs. the non‐humidified condition

 

116

1 study

⊕⊝⊝⊝
VERY LOWa

*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).

#Number of participants included in the analysis were reported, See Characteristics of included studies for number of recruited and included participants.
CI: Confidence interval; OR: Odds Ratio

GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.

aDowngraded once due to high risk of bias: lack of control for confounding.
bDowngraded once due to high risk of bias: Lack of blinding.
cDowngraded once due to high risk of bias: Other source of bias.

Figuras y tablas -
Summary of findings 3. Summary of findings 'absenteeism'
Comparison 1. Humidification vs no humidification in occupational setting

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1.1 Dry eye: Cross‐over study cluster RCT Show forest plot

1

Odds Ratio (IV, Random, 95% CI)

Totals not selected

1.1.1 6 weeks

1

Odds Ratio (IV, Random, 95% CI)

Totals not selected

1.2 Dry Eye: Cross‐over Studies cluster non‐RCT Show forest plot

2

Odds Ratio (IV, Random, 95% CI)

0.58 [0.27, 1.25]

1.2.1 6 ‐12 weeks

2

Odds Ratio (IV, Random, 95% CI)

0.58 [0.27, 1.25]

1.3 Dry Eye: Before‐and‐after studies Show forest plot

2

102

Odds Ratio (M‐H, Random, 95% CI)

0.57 [0.23, 1.41]

1.3.1 After 6 weeks ‐ 4 months

2

102

Odds Ratio (M‐H, Random, 95% CI)

0.57 [0.23, 1.41]

1.4 Dry Eye: Before‐and‐after studies Show forest plot

2

Odds Ratio (M‐H, Random, 95% CI)

Totals not selected

1.4.1 Before

1

Odds Ratio (M‐H, Random, 95% CI)

Totals not selected

1.4.2 After 6 weeks

1

Odds Ratio (M‐H, Random, 95% CI)

Totals not selected

1.4.3 Before

1

Odds Ratio (M‐H, Random, 95% CI)

Totals not selected

1.4.4 After 4 months

1

Odds Ratio (M‐H, Random, 95% CI)

Totals not selected

1.5 Eye: Change in breakup time of tears (s) Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.6 Dry Skin: Crossover studies cluster non‐RCT Show forest plot

2

(IV, Random, 95% CI)

0.66 [0.33, 1.32]

1.6.1 6 ‐12 weeks

2

(IV, Random, 95% CI)

0.66 [0.33, 1.32]

1.7 Skin Symptoms: Cross‐over study cluster RCT Show forest plot

1

Odds Ratio (IV, Random, 95% CI)

Totals not selected

1.7.1 6 weeks

1

Odds Ratio (IV, Random, 95% CI)

Totals not selected

1.8 Dry Skin: Before‐and‐after studies Show forest plot

2

Odds Ratio (M‐H, Fixed, 95% CI)

Totals not selected

1.8.1 Before

1

Odds Ratio (M‐H, Fixed, 95% CI)

Totals not selected

1.8.2 After 4 months

1

Odds Ratio (M‐H, Fixed, 95% CI)

Totals not selected

1.8.3 Before

1

Odds Ratio (M‐H, Fixed, 95% CI)

Totals not selected

1.8.4 After 12 weeks

1

Odds Ratio (M‐H, Fixed, 95% CI)

Totals not selected

1.9 Dry skin: Before‐and‐after studies Show forest plot

2

121

Odds Ratio (M‐H, Fixed, 95% CI)

0.69 [0.33, 1.47]

1.9.1 after 12 weeks to 4 months

2

121

Odds Ratio (M‐H, Fixed, 95% CI)

0.69 [0.33, 1.47]

1.10 Skin Symptoms: Before‐and‐after studies Show forest plot

1

Risk Difference (M‐H, Fixed, 95% CI)

Totals not selected

1.10.1 Before

1

Risk Difference (M‐H, Fixed, 95% CI)

Totals not selected

1.10.2 After 6 weeks

1

Risk Difference (M‐H, Fixed, 95% CI)

Totals not selected

1.11 Dry Nose: Cross‐over study cluster non‐RCT Show forest plot

1

Odds Ratio (IV, Random, 95% CI)

Totals not selected

1.11.1 6 weeks

1

Odds Ratio (IV, Random, 95% CI)

Totals not selected

1.12 Dry Nose: Cross‐over study cluster RCT Show forest plot

1

Odds Ratio (IV, Random, 95% CI)

Totals not selected

1.12.1 6 weeks

1

Odds Ratio (IV, Random, 95% CI)

Totals not selected

1.13 Nose Symptoms: Before‐and‐after studies Show forest plot

1

Odds Ratio (M‐H, Fixed, 95% CI)

Totals not selected

1.13.1 Before

1

Odds Ratio (M‐H, Fixed, 95% CI)

Totals not selected

1.13.2 After 6 weeks

1

Odds Ratio (M‐H, Fixed, 95% CI)

Totals not selected

1.14 Change of nasal signs Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.14.1 MCA1 (minimum cross‐sectional areas), cm2

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.14.2 MCA2 (minimum cross‐sectional areas), cm2

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.14.3 VOL1(volume of the nasal cavity), cm3

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.14.4 VOL2 (volume of the nasal cavity), cm3

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.14.5 ECP (eosinophilic cationic proein), µg/l

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.14.6 MPO (myeloperoxidase), µg/l

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.14.7 Lyosozyme, mg/l

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.14.8 Albumin, mg/l

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.15 Airway Symptoms: Before‐and‐after studies Show forest plot

1

Odds Ratio (M‐H, Fixed, 95% CI)

Totals not selected

1.15.1 Before

1

Odds Ratio (M‐H, Fixed, 95% CI)

Totals not selected

1.15.2 After 4 months

1

Odds Ratio (M‐H, Fixed, 95% CI)

Totals not selected

1.16 Dry mouth and throat: Cross‐over study cluster non‐RCT Show forest plot

1

Odds Ratio (IV, Fixed, 95% CI)

Totals not selected

1.16.1 12 weeks

1

Odds Ratio (IV, Fixed, 95% CI)

Totals not selected

1.17 Pharyngeal Dryness: Cross‐over study cluster non‐RCT Show forest plot

1

Odds Ratio (IV, Random, 95% CI)

Totals not selected

1.17.1 6 weeks

1

Odds Ratio (IV, Random, 95% CI)

Totals not selected

1.18 Pharyngeal Dryness: Cross‐over study cluster RCT Show forest plot

1

Odds Ratio (IV, Random, 95% CI)

Totals not selected

1.18.1 6 weeks

1

Odds Ratio (IV, Random, 95% CI)

Totals not selected

1.19 Perception of dryness: Cross‐over study cluster RCT Show forest plot

1

Odds Ratio (IV, Random, 95% CI)

Totals not selected

1.19.1 6 weeks

1

Odds Ratio (IV, Random, 95% CI)

Totals not selected

1.20 Perception of dryness: Cross‐over study cluster non‐RCT Show forest plot

1

Odds Ratio (IV, Random, 95% CI)

Totals not selected

1.20.1 12 weeks

1

Odds Ratio (IV, Random, 95% CI)

Totals not selected

1.21 Perception of dryness: Before‐and‐after study Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.21.1 Before

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.21.2 After 6 weeks

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.22 Perception of dryness: Before‐and‐after study Show forest plot

1

Odds Ratio (M‐H, Fixed, 95% CI)

Totals not selected

1.22.1 Before

1

Odds Ratio (M‐H, Fixed, 95% CI)

Totals not selected

1.22.2 After 3 months

1

Odds Ratio (M‐H, Fixed, 95% CI)

Totals not selected

1.23 Increased perception of dryness: Before‐and‐after study Show forest plot

1

Odds Ratio (M‐H, Fixed, 95% CI)

Totals not selected

1.23.2 Change after 4 months

1

Odds Ratio (M‐H, Fixed, 95% CI)

Totals not selected

1.24 Decreased perception of dryness: Before‐and‐after study Show forest plot

1

Odds Ratio (M‐H, Random, 95% CI)

Totals not selected

1.24.1 Change after 4 months

1

Odds Ratio (M‐H, Random, 95% CI)

Totals not selected

1.25 Perception of dryness: Before‐and‐after studies Show forest plot

2

82

Std. Mean Difference (IV, Random, 95% CI)

‐0.48 [‐3.49, 2.54]

1.25.1 Change after 1‐4 months

2

82

Std. Mean Difference (IV, Random, 95% CI)

‐0.48 [‐3.49, 2.54]

1.26 Perception of dryness: Before‐and‐after studies Show forest plot

2

Odds Ratio (IV, Fixed, 95% CI)

0.05 [0.01, 0.22]

1.26.1 After 4 to 6 weeks

2

Odds Ratio (IV, Fixed, 95% CI)

0.05 [0.01, 0.22]

1.27 Perception of stuffiness: Cross‐over study cluster RCT Show forest plot

1

Odds Ratio (IV, Random, 95% CI)

2.18 [1.47, 3.23]

1.27.1 6 weeks

1

Odds Ratio (IV, Random, 95% CI)

2.18 [1.47, 3.23]

1.28 Perception of stuffiness: Cross‐over study cluster non‐RCT Show forest plot

1

Odds Ratio (IV, Random, 95% CI)

Totals not selected

1.28.1 6 weeks

1

Odds Ratio (IV, Random, 95% CI)

Totals not selected

1.29 Perception of stuffiness: Before‐and‐after studies Show forest plot

2

82

Std. Mean Difference (IV, Random, 95% CI)

0.24 [‐0.30, 0.78]

1.29.1 Change after 1‐4 months

2

82

Std. Mean Difference (IV, Random, 95% CI)

0.24 [‐0.30, 0.78]

1.30 Perception of stuffiness: Before‐and‐after studies Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.30.1 Before

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.30.2 After 1‐3 months

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.31 Increased perception of stuffiness: Before‐and‐after studies Show forest plot

1

Odds Ratio (M‐H, Random, 95% CI)

Totals not selected

1.31.1 Change after 4 months

1

Odds Ratio (M‐H, Random, 95% CI)

Totals not selected

1.32 Decreased perception of stuffiness: Before‐and‐after studies Show forest plot

1

Odds Ratio (M‐H, Random, 95% CI)

Totals not selected

1.32.1 Change after 4 months

1

Odds Ratio (M‐H, Random, 95% CI)

Totals not selected

1.33 Absenteeism: Controlled Study non‐RCT Show forest plot

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.33.1 Time period: 1973‐1974

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.33.2 Time period: 1974‐1975

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

1.33.4 Time period: 1975‐1976

1

Mean Difference (IV, Fixed, 95% CI)

Totals not selected

Figuras y tablas -
Comparison 1. Humidification vs no humidification in occupational setting
Comparison 2. Humidification vs no humidification in educational setting

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

2.1 Absenteeism due to cold symptoms: Controlled Study non‐RCT Show forest plot

1

12749

Odds Ratio (M‐H, Random, 95% CI)

0.54 [0.45, 0.65]

2.2 Average days of absence per child: Controlled Study non‐RCT Show forest plot

1

Other data

No numeric data

2.3 Average weekly absense: Controlled Study non‐RCT Show forest plot

1

263

Odds Ratio (M‐H, Random, 95% CI)

0.38 [0.15, 0.96]

2.4 Average total absenteeism: Controlled Study (1960‐1971) non‐RCT Show forest plot

1

Other data

No numeric data

2.5 Absenteeism due to sickness: Controlled Study non‐RCT Show forest plot

1

Other data

No numeric data

2.6 Absenteeism due to influenza like illness: Controlled Study non‐RCT Show forest plot

1

Other data

No numeric data

Figuras y tablas -
Comparison 2. Humidification vs no humidification in educational setting